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Abstract
The qualiﬁed presumption of safety (QPS) procedure was developed to provide a harmonised generic
pre-evaluation to support safety risk assessments of biological agents performed by EFSA’s Scientiﬁc
Panels. The taxonomic identity, body of knowledge, safety concerns and antimicrobial resistance were
assessed. Safety concerns identiﬁed for a taxonomic unit are, where possible and reasonable in
number, reﬂected by ‘qualiﬁcations’ which should be assessed at the strain level by the EFSA’s
Scientiﬁc Panels. During the current assessment, no new information was found that would change the
previously recommended QPS taxonomic units and their qualiﬁcations. Between April and September
2018, the QPS notiﬁcation list was updated with 48 microorganisms from applications for market
authorisation. Of these, 30 biological agents already had QPS status, 15 were excluded from the QPS
exercise by the previous QPS mandate (ﬁve ﬁlamentous fungi) or from further evaluations within the
current mandate (two notiﬁcations of Enterococcus faecium, one of Streptomyces spp. and seven of
Escherichia coli). One taxonomic unit was (re)evaluated: Pseudomonas ﬂuorescens had been
previously evaluated in 2016, and was now re-evaluated within this mandate. The revision of the
literature supports the previously identiﬁed safety concerns (e.g. production of biocompounds with
antimicrobial activity and virulence features), preventing the inclusion of P. ﬂuorescens in the QPS list.
Mycobacterium setense and Komagataeibacter sucrofermentans were evaluated for the ﬁrst time.
M. setense cannot be considered for the QPS assessment because there are signiﬁcant safety
concerns. K. sucrofermentans (Acetobacter xylinus subsp. sucrofermentans) can be proposed for the
QPS list but only for production purposes. The QPS status of Corynebacterium glutamicum is conﬁrmed
with the qualiﬁcation extended to other production purposes.
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Summary
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to
deliver a Scientiﬁc Opinion on the maintenance of the list of qualiﬁed presumption of safety (QPS)
biological agents intentionally added to food or feed. The request included three speciﬁc tasks as
mentioned in the Terms of Reference (ToR).
The QPS process was developed to provide a harmonised generic pre-evaluation procedure to
support safety risk assessments of biological agents performed by EFSA’s scientiﬁc Panels and Units.
The taxonomic identity, body of knowledge and safety of biological agents are assessed. Safety
concerns identiﬁed for a taxonomic unit (TU) are, where possible and reasonable in number, reﬂected
as ‘qualiﬁcations’ that should be assessed at the strain level by the EFSA’s scientiﬁc Panels. A generic
qualiﬁcation for all QPS bacterial TUs applies in relation to the absence of acquired genes conferring
resistance to clinically relevant antimicrobials (EFSA, 2008).3
The evaluation is undertaken every 3 years in a scientiﬁc Opinion of the BIOHAZ Panel. Meanwhile,
the list of microorganisms is maintained and re-evaluated approximately every 6 months in a
Panel Statement. If new information is retrieved from extended literature searches that would change
the QPS status of a microbial species or its qualiﬁcations, this is published in the Panel Statement. The
Panel Statement also includes the evaluation of microbiological agents notiﬁed to EFSA within the 6-
month period for an assessment for use as feed additives, food enzymes, food additives and
ﬂavourings, novel foods or plant protection products (PPP). The main results of the assessments
completed from 2017 will be included in the scientiﬁc Opinion of the BIOHAZ Panel to be published by
the end of the current mandate in December 2019. In the interim, as a result of each Panel Statement,
the ‘2016 updated list of QPS status recommended biological agents for safety risk assessments carried
out by EFSA scientiﬁc Panels and Units’ is extended by the inclusion of new recommendations for QPS
status, and appended to the Opinion adopted in December 2016 (Appendix E).
The ﬁrst ToR requires ongoing updates of the list of biological agents notiﬁed to EFSA, in the
context of a technical dossier, for intentional use in food and/or feed or as sources of food and feed
additives, enzymes and PPP for safety assessment. The list was updated with the notiﬁcations received
since the latest review in March 2018. Within this period, 48 notiﬁcations were received by EFSA, of
which 41 were for feed additives, three for food enzymes, food additives and ﬂavourings, four for
novel foods and none for PPP. The new notiﬁcations, received between April and September 2018, are
included in a table appended to the current Statement (Appendix F).
The second ToR concerns the revision of the TUs previously recommended for the QPS list and their
qualiﬁcations when new information has become available, and the updating of the information
provided in the previous Opinion adopted in December 2016. According to the articles retrieved
through an extensive literature search (ELS), for articles published from January to June 2018 no new
information was found that would affect the QPS status of those TUs and their qualiﬁcations.
The third ToR requires a (re)assessment of TUs notiﬁed to EFSA, but not present in the current QPS list,
for their suitability for inclusion in the updated list. The current Statement focuses on the assessments of the
TUs that were notiﬁed to EFSA between April 2018 and September 2018. Of the 48 notiﬁcations received,
30 biological agents already had QPS status and did not require further evaluation in this Statement and 15
were not included because: ﬁve were notiﬁcations of ﬁlamentous fungi that were excluded from the QPS
exercise; two were notiﬁcations of Enterococcus faecium, one of Streptomyces spp. and seven of
Escherichia coli that were excluded from further QPS evaluations within the current QPS mandate. Three
new TUs were considered for the QPS assessment within this Statement: Pseudomonas ﬂuorescens, already
evaluated in 2016 (EFSA BIOHAZ Panel, 2017a), and was re-evaluated within this mandate and
Mycobacterium setense and Komagataeibacter sucrofermentans, which were evaluated for the ﬁrst time.
The revision of the literature supports the previous identiﬁed safety concerns (e.g. production
of biocompounds with antimicrobial activity and virulence features), preventing the inclusion of
P. ﬂuorescens in the QPS list. M. setense cannot be considered for the QPS assessment because there
are signiﬁcant safety concerns. K. sucrofermentans (Acetobacter xylinus subsp. sucrofermentans) can
be proposed for the QPS list but only for production purposes.
In parallel to the standard procedure for assessing a TU for a possible QPS status, in relation to
Corynebacterium glutamicum, and in response to a request from an EFSA unit, it was decided to run a
complementary reassessment for another speciﬁc end-use as the QPS qualiﬁcation ‘only applies when
the species is used for amino acid production’. The QPS status of C. glutamicum is conﬁrmed with the
qualiﬁcation extended to other production purposes.
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1. Introduction
The qualiﬁed presumption of safety (QPS) approach was developed by the EFSA Scientiﬁc
Committee to provide a generic concept to prioritise and to harmonise risk assessment within the
European Food Safety Authority (EFSA) of microorganisms intentionally introduced into the food chain,
in support of the respective Scientiﬁc Panels and Units in the frame of market authorisations (EFSA,
2007a). The list, ﬁrst established in 2007, has been continuously revised and updated. The publication
of the overall assessment of the taxonomic units (TUs) previously recommended for the QPS list is to
be evaluated every 3 years through a scientiﬁc Opinion by the Panel on Biological Hazards (BIOHAZ).
Intermediate deliverables in the form of a Panel Statement are produced and published for periods of
around 6 months, should an assessment for a QPS classiﬁcation of a microbiological agent notiﬁed to
EFSA be requested by the Units dealing with feed additives, food enzymes, food additives and
ﬂavourings, novel foods, or plant protection products. These Panel Statements also include the results
of the assessment of the relevant new papers related to the TUs with QPS status.
1.1. Background and Terms of Reference as provided by EFSA
1.1.1. Background as provided by EFSA
A wide variety of microorganisms are intentionally added at different stages into the food and feed
chain. In the context of applications for market authorisation of these biological agents, used either
directly or as sources of food and feed additives, food enzymes and plant protection products, EFSA is
requested to assess their safety.
Several taxonomic units (usually species for bacteria and yeasts, families for viruses) have been
included in the qualiﬁed presumption of safety (QPS) list either following notiﬁcations to EFSA or
proposals made initially by stakeholders during a public consultation in 2005, even if they were not yet
notiﬁed to EFSA (EFSA, 2005).1 The EFSA Scientiﬁc Committee reviewed the range and numbers of
microorganisms likely to be the subject of an EFSA Opinion and published in 2007 a list of
microorganisms recommended for the QPS list.2
In 2007, the Scientiﬁc Committee recommended that a QPS approach should provide a generic
concept to prioritise and to harmonise safety risk assessment of microorganisms intentionally
introduced into the food chain, in support of the respective Scientiﬁc Panels and EFSA Units in the
frame of the market authorisations. The same Committee recognised that there would have to be
continuing provision for reviewing and modifying the QPS list and in line with this recommendation, the
EFSA Scientiﬁc Panel on Biological Hazards (BIOHAZ) took the prime responsibility for this and started
reviewing annually the existing QPS list. The ﬁrst annual QPS update3 was published in 2008 and
EFSA’s initial experience in applying the QPS approach was included. The potential application of the
QPS approach to microbial plant protection products was discussed in the 2009 update.4 Also in 2009,
bacteriophages were assessed and were not considered appropriate for the QPS list. After consecutive
years of reviewing the existing scientiﬁc information, the ﬁlamentous fungi (2008 to 2013 updates) and
enterococci (2010 to 2013 updates) were not recommended for the QPS list. The 2013 update5 of the
recommended QPS list included 53 species of Gram-positive non-spore-forming bacteria, 13 Gram-
positive spore forming bacteria (Bacillus species), one Gram-negative bacterium (Gluconobacter
oxydans), 13 yeast species, and three virus families.
In 2014 the BIOHAZ Panel, in consultation with the Scientiﬁc Committee, decided to change the
revision procedure: the overall assessment of the taxonomic units previously recommended for the
QPS list is no longer carried out annually but over 3-year periods. From 2017, the search and revision
of the possible safety concerns linked to those taxonomic units start to be done every 6 months
1 Opinion of the Scientiﬁc Committee on a request from EFSA related to a generic approach to the safety assessment by EFSA of
microorganisms used in food/feed and the production of food/feed additives. EFSA Journal 2005;226, 1–12.
2 Introduction of a Qualiﬁed Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA -
Opinion of the Scientiﬁc Committee. EFSA Journal 2007;293, 1–85.
3 Scientiﬁc Opinion of the Panel on Biological Hazards on a request from EFSA on the maintenance of the list of QPS
microorganisms intentionally added to food or feed. EFSA Journal 2008;923, 1–48.
4 Scientiﬁc Opinion of the Panel on Biological Hazards (BIOHAZ) on the maintenance of the list of QPS microorganisms
intentionally added to food or feed (2009 update). EFSA Journal 2009;7(12):1431, 92 pp. https://doi.org/10.2903/j.efsa.2009.
1431
5 EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientiﬁc Opinion on the maintenance of the list of QPS
biological agents intentionally added to food and feed (2013 update). EFSA Journal 2013;11(11):3449, 107 pp. https://doi.org/
10.2903/j.efsa.2013.3449
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period. The update of the 2013 QPS list version (EFSA BIOHAZ Panel, 2013) was done in 2016 (EFSA
BIOHAZ Panel, 2017a) and the next update will be published in a scientiﬁc Opinion of the BIOHAZ
Panel after its adoption in December 2019.6 The QPS list of microorganisms has been maintained and
frequently checked, based on the evaluation of extensive literature searches. In the meantime and
every 6 months, a Panel Statement, compiling the assessments for a QPS status of the microbiological
agents notiﬁed to EFSA requested by the Feed Unit, the Food Ingredients and Packaging (FIP) Unit,
the Nutrition Unit or by the Pesticides Unit, has been produced and published. In the follow up of the
2013 update5 the Scientiﬁc Committee agreed to exclude some biological groups (ﬁlamentous fungi,
bacteriophages and Enterococcus faecium7) notiﬁed to EFSA from the QPS assessment because it was
considered unlikely that any taxonomical units within these groups would be granted QPS status in the
foreseeable future. Thus, the assessment of members of these biological groups needs to be done at a
strain level, on a case-by-case basis, by the relevant EFSA Unit.
The QPS provides a generic safety pre-assessment approach for use within EFSA that covers risks
for human, animals and the environment. In the QPS concept a safety assessment of a deﬁned
taxonomic unit is considered independently of any particular speciﬁc notiﬁcation in the course of an
authorisation process. The QPS concept does not address hazards linked to the formulation or other
processing of the products containing the microbial agents and added into the food or feed chain.
Although general human safety is part of the evaluation, speciﬁc issues connected to type and level of
exposure of users handling the product (e.g. dermal, inhalation, ingestion) are not addressed. In the
case Genetically Modiﬁed Microorganisms (GMM) for which the species of the recipient strain qualiﬁes
for the QPS status, and for which the genetically modiﬁed state does not give rise to safety concerns,
the QPS approach can be extended to genetically modiﬁed production strains (EFSA BIOHAZ Panel,
2018a).8 Assessment of potential allergenicity to microbial residual components is beyond the QPS
remit; if there is however, science-based evidence for some microbial species it is reported. Where
applicable these aspects are assessed, separately by the EFSA Panel responsible for assessing the
notiﬁcation. Antimicrobial resistance was introduced as a possible safety concern for the assessment of
the inclusion of bacterial species in the QPS list published in 2008 QPS Opinion (EFSA, 2008)3. In the
2009 QPS Opinion (EFSA BIOHAZ Panel, 2009)4 a qualiﬁcation regarding the absence of antimycotic
resistance for yeasts was introduced.
1.1.2. Terms of Reference as provided by EFSA
The Terms of Reference, as provided by EFSA are as follows:
ToR 1: Keep updated the list of biological agents being notiﬁed in the context of a technical dossier
to EFSA Units such as Feed, Pesticides, Food Ingredients and Packaging (FIP) and Nutrition, for
intentional use directly or as sources of food and feed additives, food enzymes and plant protection
products for safety assessment.
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualiﬁcations
when new information has become available. The latter is based on a review of the updated literature
aiming at verifying if any new safety concern has arisen that could require the removal of the
taxonomic unit from the list, and to verify if the qualiﬁcations still efﬁciently exclude safety concerns.
ToR 3: (Re) assess the suitability of new taxonomic units notiﬁed to EFSA for their inclusion in the
QPS list. These microbiological agents are notiﬁed to EFSA and requested by the Feed Unit, the FIP
Unit, the Nutrition Unit or by the Pesticides Unit.
1.2. Interpretation of the Terms of Reference
The absence of acquired genes conferring resistance to clinically relevant antimicrobials is a
qualiﬁcation9 applied to all QPS bacterial TUs. The veriﬁcation of such qualiﬁcation is under the remit
of the Unit conducting the safety assessment of the organism notiﬁed to EFSA for market
authorisation, therefore is done at strain level (EFSA BIOHAZ Panel, 2017a).
6 References updated from the original self-task mandate.
7 The taxonomic unit was corrected from the original mandate: ‘enterococci’. It is only referred to Enterococcus faecium, the only
species which was evaluated for a possible QSP status.
8 Sentence included, correcting the previous sentence from the original self-task mandate: ‘Genetically modiﬁed microorganisms
are similarly not taken into account’.
9 Identiﬁed safety concerns, including acquired antimicrobial resistance genes, for a certain TU can be, where reasonable in
number and not universally present, reﬂected as ‘qualiﬁcations’.
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In June of 2017 (EFSA BIOHAZ Panel, 2017b), the BIOHAZ Panel has agreed to exclude Escherichia
coli and any species of the genus Streptomyces from QPS evaluation within this mandate.
In June of 2018 (EFSA BIOHAZ Panel, 2018b), the BIOHAZ Panel clariﬁed that the qualiﬁcation ‘for
production purpose only’ implies the absence of viable cells of the production organism in the ﬁnal
product and can also be applied for food and feed products based on microbial biomass.
2. Data and methodologies
2.1. Data
Only valid TUs covered by the relevant international committees on the nomenclature for
microorganisms are considered for the QPS assessment.
In reply to ToR 3, (re)assessment of the suitability of TUs notiﬁed within the time period covered by
this Statement (from April to September 2018) is carried out. The literature review considered the
identiﬁcation, the body of knowledge, the potential safety concerns, and the knowledge on acquired
antimicrobial resistance (AMR). Relevant databases, such as PubMed, Web of Science, Cases Database,
CAB Abstracts or Food Science Technology Abstracts (FSTA) and Scopus, were searched. More details
on the search strategy, search keys, and approach are described in Appendix A.
In reply to ToR 2, concerning the revision of the TUs previously recommended for the QPS list and
their qualiﬁcations, an extensive literature search (ELS) was conducted as described in Appendices B
and C.
2.2. Methodologies
2.2.1. Evaluation of a QPS recommendation for Taxonomic Units notiﬁed to EFSA
In response to ToR 1, the EFSA Units were asked to update the list of biological agents being
notiﬁed to EFSA. A total of 48 notiﬁcations were received between April and September 2018, of which
41 were for a feed additive, three for food enzymes, food additives and ﬂavourings, four for novel
foods and none for plant protection products (Table 1).
In response to ToR 3, out of the 48 notiﬁcations, 30 were related to TUs that already had QPS
status and did not require further evaluation. Of the remaining 18 notiﬁcations, 15 were related to TUs
not evaluated for a QPS status for the following reasons:
• Five notiﬁcations related to ﬁlamentous fungi, which were excluded from QPS evaluations in
the follow up of a recommendation of the QPS 2013 and 2016 updates (EFSA BIOHAZ Panel,
2013, 2014, 2016),
• Seven notiﬁcation related to E. coli, one to Streptomyces spp. and two of Enterococcus
faecium, which were recently excluded from the current mandate by the BIOHAZ Panel.
The TUs corresponding to the remaining three notiﬁcations were now evaluated (or re-evaluated if
they had been evaluated prior to 2016) for possible QPS recommendation:
• Pseudomonas ﬂuorescens already evaluated in 2016 and not granted QPS status (EFSA
BIOHAZ Panel, 2017a),
• Mycobacterium setense and Komagataeibacter sucrofermentans, both evaluated for the ﬁrst
time.
In parallel to the standard procedure for assessing a TU for a possible QPS status, and in response
to a request from an EFSA unit, in relation to Corynebacterium glutamicum, it was decided to run a
complementary reassessment for another speciﬁc end-use as the QPS qualiﬁcation ‘only applies when
the species is used for amino acid production’, considering that some time passed by since 2016 and
that new data may have been published.
The notiﬁcations received by EFSA, per risk assessment area, by biological group from April to
September 2018 are presented in Table 1.
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2.2.2. Monitoring of new safety concerns related to the QPS list
The aim of the ELS carried out in response to ToR 2 (review of the recommendations for the QPS
list and speciﬁc qualiﬁcations) was to identify any publicly available studies reporting on safety
concerns for humans, animals or the environment caused by QPS organisms since the previous QPS
review (i.e. publications from January to June 2018). For a detailed protocol of the process and search
strategies, refer to Appendices B and C.
After removal of duplicates, 3,034 records were submitted to the title screening step, which led to
the exclusion of 2,918 of them. The remaining 116 records were found eligible for the Title and
abstract screening step, which led to the exclusion of 58 of these. Of the 58 articles that ﬁnally
reached the Article evaluation step (full text), 35 were considered to be relevant for the QPS project.
The ﬂow of records from their identiﬁcation by the different search strategies (as reported in
Appendix C) to their consideration potentially relevant papers for QPS, is shown in Table 2.
Table 1: Notiﬁcations received by EFSA, per risk assessment area and by biological group, from
April to September 2018
Risk assessment area Not evaluated in this statement Evaluated
in this
statement
Total
Biological group
Already
QPS
Excluded in QPS(a)
Feed additives 28 12 1 41
Bacteria 22 8 1 31
Filamentous fungi 0 4 0 4
Yeasts 6 0 0 6
Novel foods 1 1 2 4
Bacteria 1 1 2 4
Plant protection products 0 0 0 0
Food enzymes, food additives
and ﬂavourings
1 2 0 3
Bacteria 1 1 0 2
Filamentous fungi 0 1 0 1
Total 30 15 3 48
QPS: qualiﬁed presumption of safety.
(a): The number includes ﬁlamentous fungi or enterococci excluded from QPS evaluation in the 2013 QPS Opinion, other
bacterial species (seven notiﬁcations of E. coli, one of Streptomyces spp. and two of Enterococcus faecium) already
excluded in the Panel Statement adopted in December 2016 (EFSA BIOHAZ Panel, 2017a).
Table 2: Flow of records by search strategy
Species
No. papers
Title
screening
step****
Title/
abstract
screening
step****
Article evaluation
step (screening
for potential
relevance)
Article evaluation
step (identiﬁcation
of potential safety
concerns)
Bacteria 1,750 57 23 14
Bacillus spp. 537 3 2 1
Biﬁdobacterium spp. 168 17 6 1
Carnobacterium divergens 0
Corynebacterium glutamicum 47 0 0 0
Gluconobacter oxydans 132 2 0 0
Xanthomonas campestris 1 0
Lactobacillus spp. 426 13 7 7
Lactococcus lactis 152 9 4 4
Leuconostoc spp. 44 9 3 1
Microbacterium imperiale 0 0
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3. Assessment
3.1. Taxonomic Units evaluated during the previous QPS mandate and
re-evaluated in the current Statement
3.1.1. Pseudomonas ﬂuorescens
P. ﬂuorescens has been previously evaluated and was not included in the QPS list (EFSA BIOHAZ
Panel, 2017a).
3.1.1.1. Identity
Since the last update on the QPS status (EFSA BIOHAZ Panel, 2016) no new information on the
taxonomy of P. ﬂuorescens has been published.
3.1.1.2. Body of knowledge
P. ﬂuorescens is a ubiquitous bacterium commonly encountered in aquatic, aerial, and soil matrices,
as well as on rhizospheres and surfaces of plants, and also colonises mammalian hosts (Bergsma-Vlami
et al., 2005; Dickson et al., 2014).
This metabolically versatile species produces a large number of secondary metabolites enabling it to
succeed in competing with other microorganisms, and also making it of interest for biotechnology
applications, namely, for use as a plant-growth promoter. Rhizosphere-inhabiting P. ﬂuorescens
produces compounds with antimicrobial activities (e.g. pyrrolnitrin) (Ramette et al., 2003; Mavrodi
et al., 2006), which might contribute to natural plant protection from phytopathogens. Moreover, the
production of mupirocin, used for prevention of methicillin-resistant Staphylococcus aureus infections,
is also attributed to P. ﬂuorescens (Sutherland et al., 1985; Villiger et al., 1986; Umio et al., 1987;
Ligon et al., 2000).
Species
No. papers
Title
screening
step****
Title/
abstract
screening
step****
Article evaluation
step (screening
for potential
relevance)
Article evaluation
step (identiﬁcation
of potential safety
concerns)
Oenococcus oeni 43 0 0 0
Pasteuria nishizawae 0 0
Pediococcus spp. 126 1 0 0
Propionibacterium spp. 30 1 0 0
Streptococcus thermophilus 45 2 0 0
Viruses 74 1 0 0
Alphaﬂexiviridae 26 0 0 0
Baculoviridae 48 1 0 0
Yeasts 1,210 58 35** 21*, **, ***
Candida famata (teleomorph =
Debaryomyces hansenii)
1210 58 35 5
Candida kefyr (teleomorph =
Kluyveromyces marxianus)
13
Candida pelliculosa 2
Hanseniaspora uvarum 1
Saccharomyces cerevisiae
including Saccharomyces boulardii
5
Total 3,034 116 58 35
Excluded 2,918 58 23
*: 21 relevant articles with 26 studies as some articles describe possible safety concerns linked to more than one TU.
**: More details can be found in Table D.1 in Appendix D.
***: For the other yeast species with QPS status, no relevant studies were identiﬁed through the ELS.
****: For practical reasons, some TUs were grouped for the screening steps.
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3.1.1.3. Safety concerns
In humans, P. ﬂuorescens has long been considered to be an opportunistic pathogen, involved in acute
nosocomial infections. Most of those infections are iatrogenic, affect the bloodstream, and are attributable
to the use of contaminated equipment used for intravenous infusion (Oba et al., 2017). In fact, it is
considered as a platelet transfusion-relevant microorganism by WHO (Spindler-Raffel et al., 2017).
While signiﬁcantly less virulent than P. aeruginosa, different features of P. ﬂuorescens have been
associated with the ability to cause disease in humans (e.g. production of haemolysins, siderophores,
type III secretion system and the ability to form bioﬁlms) (Scales et al., 2014; Mazurier et al., 2015).
3.1.1.4. Antimicrobial resistance aspects
P. ﬂuorescens can present antimicrobial resistance due to intrinsic and acquired antimicrobial
resistance mechanisms (EFSA, 2007a). No new relevant information on AMR has been described.
3.1.1.5. Conclusions on a recommendation for the QPS list
The revision of the literature supports the previous identiﬁed safety concerns (e.g. production
of biocompounds with antimicrobial activity and virulence features), preventing the inclusion of
P. ﬂuorescens in the QPS list.
3.2. Taxonomic Units to be evaluated for the ﬁrst time
3.2.1. Mycobacterium setense
3.2.1.1. Identity
M. setense is a member of the Mycobacterium fortuitum complex, being more closely related,
based on the sequence of the 16S rRNA gene, to Mycobacterium houstonense and Mycobacterium
senegalense and on the sequence of the rpoB gene, to Mycobacterium conceptionense.
3.2.1.2. Body of knowledge
It is recognised that non-tuberculous mycobacteria are ubiquitously distributed in the environment,
where they can be isolated from water and soil (Tortoli, 2014). Nevertheless, there is a paucity of data
regarding this species’ habitat. Recently, a strain from this species (strain Manresensis) that was
isolated from river water was claimed to delay tubercle bacilli colonisation into open tuberculosis in
laboratory animals when used after heat-inactivation (Cardona et al., 2015; Tukvadze et al., 2016). A
trial on human healthy volunteers seemed to indicate that its oral administration was safe in the short
term (Montane et al., 2017).
3.2.1.3. Safety concerns
M. setense is part of the M. fortuitum complex, which is well known for its ability to cause skin,
bone and joint infections (Yu et al., 2013) and mycolic acids of mycobacteria are recognised to induce
granulomatous lesions (Fujita et al., 2007).
3.2.1.4. Antimicrobial resistance aspects
No information is available in the scientiﬁc literature.
3.2.1.5. Conclusions on a recommendation for the QPS list
M. setense cannot be considered a suitable microorganism species for the QPS status because
there are signiﬁcant safety concerns.
3.2.2. Komagataeibacter sucrofermentans
3.2.2.1. Identity
The bacterial species, K. sucrofermentans (Validation List nr. 149, IJSM 2013, 63, 1-5) was previously
named Acetobacter xylinus subsp. sucrofermentans (Toyosaki et al., 1996) and Gluconacetobacter
sucrofermentans (Cleenwerck et al., 2010). The species is clearly described based on a polyphasic
approach (Cleenwerck et al., 2010).
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3.2.2.2. Body of knowledge
K. sucrofermentans strains are characterised by their ability to produce large amounts of cellulose
from sucrose in agitated cultures (Cleenwerck et al., 2010). Searching PubMed database for this species
delivered 11 hits, all concerning the cellulose production capacity. In Asia, cellulose has traditionally
been produced from the fermentation of coconut waste-water by K. sucrofermentans and used in food.
3.2.2.3. Safety concerns
No safety concerns were reported by using K. sucrofermentans.
3.2.2.4. Antimicrobial resistance aspects
No information is available.
3.2.2.5. Conclusions on a recommendation for the QPS list
K. sucrofermentans (A. xylinus subsp. sucrofermentans) can be proposed for the QPS list but only
for production purposes.
3.2.3. Extension of qualiﬁcation of Corynebacterium glutamicum
C. glutamicum has been recommended for the QPS status but the qualiﬁcation has only been
applied when the species is used for aminoacid production. In the meantime, notiﬁcations arrived to
EFSA for other production purposes and it was requested from EFSA units to extend the qualiﬁcation
to other uses.
C. glutamicum does not produce known toxic compounds. Consequently, there is no hazard related
to the presence of toxic metabolites in the fermentation broth.
The QPS status of C. glutamicum is conﬁrmed with the qualiﬁcation extended to other production
purposes.
3.3. Monitoring of new safety concerns related to organisms on the QPS
list
The summaries of the evaluation of the possible safety concerns for humans, animals or the
environment caused by QPS organisms described and published since the previous evaluation (i.e. ELS
search run between January and June 2018, as described in Appendices B and C) are presented
below. The references selected as potentially relevant for the QPS exercise are included in Appendix D
for each of the TUs or groups of TUs that are part of the QPS list (Appendix E). As already explained
in 2.2.2, for practical reasons, some TUs were grouped for the screening steps.
3.3.1. Gram-positive non-sporulating bacteria
3.3.1.1. Biﬁdobacterium spp.
Search of papers potentially relevant for the QPS consideration of Biﬁdobacterium spp. and
Carnobacterium divergens provided 168 references. The analysis of their titles left 17 articles for
consideration; the rest were discarded because they did not deal with safety concerns. Six articles
were found relevant for the QPS consideration of Biﬁdobacterium spp. at the level of title and abstract
screening (de Andres et al., 2018; Downes et al., 2018; Kim et al., 2018a; Kumar et al., 2018;
Martınez et al., 2018). After screening the entire papers, ﬁve of them were ﬁnally discarded because
they did not deal with safety concerns. The paper of Martınez et al. (2018) was kept because the
authors identiﬁed and characterised a novel gene, homolog to rRNA methylases, which confers
erythromycin and clindamycin resistance that can be found in some strains of Biﬁdobacterium spp.
Based on the available evidence as described above, the QPS status of Biﬁdobacterium spp. is not
changed.
3.3.1.2. Carnobacterium divergens
Search of papers potentially relevant for the QPS consideration of Biﬁdobacterium spp. and
Carnobacterium divergens provided 168 references. The analysis of their titles left 17 articles for
consideration; the rest were discarded because they did not deal with safety concerns. No article
arrived to the ﬁnal stage for this TU. Consequently, the QPS status of C. divergens is not changed.
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3.3.1.3. Corynebacterium glutamicum
Search of papers potentially relevant for the QPS consideration of Corynebacterium glutamicum
provided 47 references. No paper reached the ﬁnal selection phase, so no new safety concern was
found.
In parallel to the standard procedure for assessing a TU for a possible QPS status and to the
maintenance of a QPS status, it was decided to run a complementary reassessment for another
speciﬁc end-use of this TU as the QPS qualiﬁcation ‘only applies when the species is used for amino
acid production’. The QPS status of Corynebacterium glutamicum is conﬁrmed with the qualiﬁcation
extended to other production purposes.
3.3.1.4. Lactobacillus spp.
Search of papers potentially relevant for the QPS consideration of any of the 35 Lactobacillus
species included in the list, provided 426 references. Analysis of their titles left 13 articles for
consideration; the rest were discarded because they did not deal with safety concerns. Analysis of the
abstracts of these allowed the selection of seven papers that raised safety concerns (Biesiada et al.,
2018; Boumis et al., 2018; Garcıa Carretero et al., 2018; Harding-Theobald and Maraj, 2018; Kane
et al., 2018; Koyama et al., 2018; de Seynes et al., 2018). Single papers dealt with infections by L.
casei (de Seynes et al., 2018), L. plantarum (Biesiada et al., 2018), L. paracasei (Harding-Theobald
and Maraj, 2018), L. salivarius (Garcıa Carretero et al., 2018) and there were three on L. rhamnosus
(Boumis et al., 2018; Kane et al., 2018; Koyama et al., 2018).
There were methodological shortcomings on the L. casei and L. plantarum identiﬁcations (both
were done by just phenotypical methods) (Biesiada et al., 2018; de Seynes et al., 2018). All articles
involved single cases of infection of patients that suffered from predisposing illnesses such as
metastatic lung cancer (Biesiada et al., 2018), haemorrhagic telangiectasia (Boumis et al., 2018),
alcoholic cirrhosis (Harding-Theobald and Maraj, 2018), anastomotic leak from a bariatric surgery
(Garcıa Carretero et al., 2018), osteoarthritis (de Seynes et al., 2018) or were immunocompromised
after having received a bone marrow transplant (Koyama et al., 2018).
Based on the available evidence as described above, the QPS status of the lactobacilli involved in
the reported cases and, by extension, of all others included in the QPS list is not changed.
3.3.1.5. Lactococcus lactis
Search of papers potentially relevant for the QPS consideration of Lactococcus lactis provided 152
references. Analysis of their titles left nine articles for consideration; the rest were discarded because
they did not deal with safety concerns. Analysis of the abstracts allowed selection of four papers that
raised safety concerns (Georgountzos et al., 2018; Mussano et al., 2018; Tato Rodrıguez et al., 2018;
W€unnemann et al., 2018). Three of them described cases of human endocarditis (Georgountzos et al.,
2018; Tato Rodrıguez et al., 2018) and oral lesions (Mussano et al., 2018) while the fourth described
infection of the ﬁsh Alosa alosa.
However, there was no indication on how the identiﬁcation of the causal organism was done in the
case described by Georgountzos et al. (2018), and the paper by Mussano et al. (2018) reported a
polymicrobial infection from which more than 25 bacterial species were identiﬁed, including well known
pathogens, which makes the lactococcal aetiology of the lesions doubtful. The endocarditis case
presented by Tato Rodrıguez et al. (2018) affected an 80-year-old man that presented predisposing
conditions; namely, previous valve replacement and aortocoronary bypass. Finally, the ﬁsh studied by
W€unnemann et al. (2018) had been recently captured from the wild and kept in an overpopulated
tank under very low oxygen concentrations, conditions described by the authors as very stressful.
Based on the available evidence as described above, the QPS status of Lactococcus lactis is not
changed.
3.3.1.6. Leuconostoc spp.
Search of papers potentially relevant for the QPS consideration of Leuconostoc and Microbacterium
imperial provided 44 references. The analysis of their titles left nine articles for consideration; the rest
were discarded because they did not deal with safety concerns. Most of these nine papers lacked
information on the identiﬁcation procedures used to identify the infectious agents. Three papers
arrived to the full text phase. Two were immediately excluded as they were not dealing with these
TUs. One paper, Lin et al. (2018) arrived to the ﬁnal stage of the evaluation. This study describes a
case of hemophagocytic lymphohistiocytosis with Leuconostoc pseudomesenteroides bacteraemia in a
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33-year-old man with a previous medical history including unexplained anaemia and splenomegaly. The
identiﬁcation of L. pseudomesenteroides from the blood cultures was achieved by phenotypic testing.
The infections reported were extremely rare and the affected patients already suffered from
debilitating illnesses.
Based on the available evidence as described above, there is no need to change the QPS
recommendation of L. pseudomesenteroides and of other Leuconostoc species included in the QPS list.
3.3.1.7. Microbacterium imperiale
Search of papers potentially relevant for the QPS consideration of Leuconostoc and Microbacterium
imperial provided 44 references. The analysis of their titles left nine articles for consideration; the rest
were discarded because they did not deal with safety concerns. Most of these nine papers lacked
information on the identiﬁcation procedures used to identify the infectious agents. Three papers
arrived to the full text phase but were immediately excluded as they were not dealing with this TU.
Consequently, the QPS status of M. imperiale is not changed.
3.3.1.8. Oenococcus oeni
Search of papers potentially relevant for the QPS consideration of Oenococcus oeni and Pasteuria
nishizawae provided 43 references. The analysis of their titles did not leave any articles for
consideration. As no paper reached the ﬁnal selection phase, no new safety concern was found.
Consequently, the QPS status of O. oeni is not changed.
3.3.1.9. Pasteuria nishizawae
Search of papers potentially relevant for the QPS consideration of Oenococcus oeni and Pasteuria
nishizawae provided 43 references. The analysis of their titles did not leave any articles for
consideration. As no paper reached the ﬁnal selection phase, no new safety concern was found.
Consequently, the QPS status of P. nishizawae is not changed.
3.3.1.10. Pediococcus spp.
Search of papers potentially relevant for the QPS consideration of Pediococcus spp. provided 126
references. The analysis of their titles left one single article for consideration that did not reach the
ﬁnal selection phase; so, no new safety concern was found. Consequently, the QPS status of
Pediococcus spp. is not changed.
3.3.1.11. Propionibacterium spp.
Search of papers potentially relevant for the QPS consideration of Propionibacterium spp. provided
30 references. The analysis of their titles left one single article for consideration that did not reach the
ﬁnal selection phase; so, no new safety concern was found. Consequently, the QPS status of
Propionibacterium spp. is not changed.
3.3.1.12. Streptococcus thermophilus
Search of papers potentially relevant for the QPS consideration of Streptococcus thermophilus
provided 45 references. The analysis of their titles left two articles for consideration that did not reach
the ﬁnal selection phase; so, no new safety concern was found. Therefore, the QPS status of S.
thermophilus is not changed.
3.3.2. Gram-positive spore-forming bacteria
3.3.2.1. Bacillus spp.
Search of papers potentially relevant for the QPS consideration of Bacillus spp. and Geobacillus
stearothermophilus provided 537 references. The analysis of their titles left three articles for
consideration; the rest were discarded because they did not deal with safety concerns.
Two papers concerning Bacillus spp. reached the ﬁnal selection phase and were analysed in-depth
(Kim et al., 2018b; Tran et al., 2018). Tran et al. (2018) paper was excluded because there was not
enough information (conference proceedings). The work of Kim et al. (2018b), describing a case of a
pyometra in an immunosuppressed dog, presented several methodological shortcomings and therefore
the data presented were not included in the current assessment.
The ELS did not come up with any information that would change the status of the Bacillus species
included in the QPS list.
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3.3.2.2. Geobacillus stearothermophilus
Search of papers potentially relevant for the QPS consideration of Bacillus spp. and Geobacillus
stearothermophilus provided 537 references. The analysis of their titles left three articles for
consideration; none of them were related to this TU. Consequently, the QPS status Geobacillus
stearothermophilus is not changed.
3.3.3. Gram-negative bacteria
3.3.3.1. Gluconobacter oxydans
Search of papers potentially relevant for the QPS consideration of Gluconobacter oxidans and
Xanthomonas campestris provided 132 references. The analysis of their titles left two articles for
consideration; the rest were discarded because they did not deal with safety concerns. No paper reached
the ﬁnal selection phase for this TU. Consequently, the QPS status of G. oxydans is not changed.
3.3.3.2. Xanthomonas campestris
Search of papers potentially relevant for the QPS consideration of Gluconobacter oxidans and
Xanthomonas campestris provided 132 references. The analysis of their titles left two articles for
consideration; the rest were discarded because they did not deal with safety concerns. One paper
(Sundin and Wang, 2018) reached the ﬁnal selection phase. It was excluded because it does not deal
with safety concerns. Consequently, the QPS status of X. campestris is not changed.
3.3.4. Yeasts
Search of papers potentially relevant for the QPS consideration of the yeasts’ species included in
the QPS list provided 1,210 references.
Thirty-ﬁve papers reached the ﬁnal step of the ELS. Fourteen of these were immediately excluded
because they were not in English or because they were not dealing with safety concerns. Thus, the
ELS identiﬁed 21 articles relevant for the different yeast species with QPS status (please refer to
Appendix D for the complete list of references).
For 6 (Kumari et al., 2018; Mohamed et al., 2018; Rajkowska and Kunicka-Styczynska, 2018; Vieira
et al., 2018; Yang and Mao, 2018; Yenisehirli et al., 2018) of these 21 references, the value of the results
and conclusions presented were very limited due to a weaknesses in the methodology used for identity
conﬁrmation of the microorganism in all references, to a lack of information regarding the source attribution
in three of them (Rajkowska and Kunicka-Styczynska, 2018; Yenisehirli et al., 2018) or to predisposing
factors in the exposed subject (Yang and Mao, 2018).
From the remaining 15 references that describe a safety concern, 13 were related to human health
(Al-Tekreeti et al., 2018; Aslani et al., 2018; Charsizadeh et al., 2018a,b,c; Jahanshiri et al., 2018;
Nejat et al., 2018; Ortiz et al., 2018; Sav et al., 2018; Scapaticci et al., 2018; Siavoshi et al., 2018;
Taverna et al., 2018; Wasilewska and Wroblewska, 2018); one to animal health (Dangarembizi et al.,
2018) and four to antimicrobial resistance (Sav et al., 2018; Scapaticci et al., 2018; Sekyere and
Asante, 2018; Taverna et al., 2018).
Out of these 15 papers describing a safety concern for one or several QPS yeast species, 10 referred to
Candida kefyr (teleomorph = Kluyveromyces marxianus) (Al-Tekreeti et al., 2018; Aslani et al., 2018;
Charsizadeh et al., 2018a,b,c; Jahanshiri et al., 2018; Nejat et al., 2018; Ortiz et al., 2018; Sav et al., 2018;
Scapaticci et al., 2018)), ﬁve to Saccharomyces cerevisiae of which one was identiﬁed as Saccharomyces
boulardii (Aslani et al., 2018; Dangarembizi et al., 2018; Scapaticci et al., 2018; Sekyere and Asante, 2018;
Wasilewska and Wroblewska, 2018)), ﬁve to Candida famata (teleomorph = Debaryomyces hansenii)
(Kumari et al. (2018); (Mohamed et al., 2018; Rajkowska and Kunicka-Styczynska, 2018; Taverna et al.,
2018; Vieira et al., 2018) and one to Hanseniaspora uvarum (Siavoshi et al., 2018).
S. cerevisiae/S. boulardii, C. famata and H. uvarum were reported to be very occasionally (up to four
studies) associated with fungal and nosocomial infections in immunocompromised or post-surgery
patients. However, 10 studies referred to C. kefyr/K. marxianus. The last one has received increased
attention in recent years, but reports where it has been unambiguously shown to be causative agent of
infectious disease in otherwise healthy individuals are very rare. There is reason to closely follow
whether there is a tendency for C. kefyr/K. marxianus to become more common in this kind of infection.
For the other yeast species with QPS status, no relevant studies were identiﬁed through the ELS.
In short, the ELS did not identify with any information that would change the status for the yeast
species included in the QPS list.
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3.3.5. Viruses used for plant protection
The ELS did not come up with any information that would change the current QPS status of any of
the virus families.
3.3.5.1. Alphaﬂexiviridae
Search of papers potentially relevant for the QPS consideration of Alphaﬂexiviridae provided 26
references. No paper reached the ﬁnal selection phase, so no new safety concern was found.
3.3.5.2. Baculoviridae
Search of papers potentially relevant for the QPS consideration of Baculoviridae provided 48
references. The analysis of their titles left one single article for consideration that did not reach the
ﬁnal selection phase, so no new safety concern was found.
4. Conclusions
ToR 1: Keep updated the list of biological agents being notiﬁed, in the context of a technical dossier
to EFSA Units (such as Feed, Food Ingredients and Packaging (FIP), Nutrition Unit and Pesticides Unit),
for intentional use in feed and/or food or as sources of food and feed additives, enzymes and plant
protection products for safety assessment:
• Between April and September 2018, the list was updated with 48 notiﬁcations that were
received by EFSA, of which 41 were for feed additives, three for food enzymes, food additives
and ﬂavourings, four for novel foods and none for plant protection products.
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualiﬁcations
when new information has become available:
• In relation to the results of the monitoring of possible new safety concerns related to the QPS
list, there were no results that justify removal of any TU from the QPS list or changes in their
respective qualiﬁcations.
ToR 3: (Re)assess the suitability of taxonomic units notiﬁed to EFSA not present in the current QPS
list for their inclusion in that list:
• The TUs corresponding to 30 out of the 48 notiﬁcations received, already had a QPS status.
• The TUs corresponding to 15 out of the 18 notiﬁcations without a QPS status were: ﬁve notiﬁcations
related to ﬁlamentous fungi which were excluded from QPS activities in the follow-up of a
recommendation of the QPS 2013 update (EFSA BIOHAZ Panel, 2013, 2014, 2016), seven
notiﬁcation related to E. coli, one to Streptomyces spp. and two to Enterococcus faecium, which were
recently excluded from the current mandate by the BIOHAZ Panel (EFSA BIOHAZ Panel, 2018a).
• Three TUs, corresponding to the other three out of those 18 notiﬁcations, were evaluated for
potential QPS recommendation: Pseudomonas ﬂuorescens already evaluated in 2016 and not granted
QPS status (EFSA BIOHAZ Panel, 2017a) was now re-evaluated within this mandate, Mycobacterium
setense and Komagataeibacter sucrofermentans, both evaluated here for the ﬁrst time.
5. Recommendations
• The revision of the literature supports the previous identiﬁed safety concerns (e.g. production
of biocompounds with antimicrobial activity and virulence features), preventing the inclusion of
P. ﬂuorescens in the QPS list.
• M. setense cannot be considered for the QPS assessment because there are signiﬁcant safety
concerns.
• K. sucrofermentans (A. xylinus subsp. sucrofermentans) can be proposed for the QPS list but
only for production purposes.
• The QPS status of Corynebacterium glutamicum is conﬁrmed with the qualiﬁcation extended to
other production purposes.
This new QPS recommendation will be included as an addition to the list of QPS status
recommended biological agents (EFSA BIOHAZ Panel, 2016), published both as an update to the
Scientiﬁc Opinion (EFSA BIOHAZ Panel, 2016) and as supporting information available on the
Knowledge Junction at https://doi.org/10.5281/zenodo.1146566.
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Glossary and Abbreviations
AMR antimicrobial resistance
BIOHAZ EFSA Panel on Biological Hazards
ELS extensive literature search
FIP EFSA Food ingredients and packaging Unit
FSTA Food Science Technology Abstracts
GMM genetically modiﬁed microorganisms
QPS qualiﬁed presumption of safety
PPP plant protection product
ToR Term of Reference
TU taxonomic unit
WG Working Group
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Appendix A – Search strategy followed for the (re)assessment of the
suitability of TUs notiﬁed to EFSA not present in the current QPS list for
their inclusion in the updated list (reply to ToR 3)
Pseudomonas ﬂuorescens
A literature search was performed in PubMed database, using the search terms “Pseudomonas
ﬂuorescens” AND (“infection” OR “risk”), from 2016: 41 hits were identiﬁed and screened. Another
search was done in Web of Science using the search terms “Pseudomonas ﬂuorescens” AND
“infection”: 94 hits were identiﬁed and screened.
Mycobacterium setense
A literature search was performed in the Web of Science, using the search term “Mycobacterium
setense”, from 2016: three hits were identiﬁed and screened.
Komagataeibacter sucrofermentans
A literature search was performed in PubMed database, using the search term “Komagataeibacter
sucrofermentans” from 2010*: 11 hits were identiﬁed, all concerning the cellulose production capacity.
*Keywords: “Acetobacter xylinus subsp. Sucrofermentans” (seven hits), “Gluconacetobacter
sucrofermentans” (nine hits, including those seven found with “Acetobacter xylinus subsp.
Sucrofermentans”), “Komagataibacter sucrofermentans” (two hits).
Another search was performed in Google: “Komagataeibacter sucrofermentans” and “taxonomy”:
three references were found.
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Appendix B – Protocol for Extensive literature search (ELS), relevance
screening, and article evaluation for the maintenance and update of list of
QPS-recommended biological agents (reply to ToR 2)
The following protocol for extensive literature search (ELS) will be used in the context of the EFSA
self-task mandate on the list of QPS-recommended biological agents intentionally added to the food or
feed (EFSA-Q-2016-00684).
B.1. Description of the process
An ELS of studies related to safety concerns for humans, animals, plants and/or the environment of
microorganisms recommended for the Qualiﬁed Presumption of Safety (QPS) 2019 list will be
performed.
The process will be performed according to the following main steps:
• ELS for potentially relevant citations;
• Relevance screening to select the citations identiﬁed by the literature search, based on titles
and abstract and then full-text;
• Evaluation of articles according to pre-speciﬁed categories of possible safety concerns;
• Discussion between experts to come to collective expert evaluation of the outcome, reﬂected
in the QPS Opinion and Panel Statements.
Considering the purpose of the QPS approach, a broad search will be performed.
The review questions will be broken down into key elements using the PECO conceptual model:
• Population of interest (P);
• Exposure of interest (E);
• Comparator (C);
• Outcomes of interest (O).
B.1.1. Objective
The aim is to identify any publicly available studies reporting on safety concerns for humans,
animals or the environment caused by microorganisms on the QPS recommended list (see
Appendix E).
B.1.2. Target population
The populations of interest are humans, animals, plants and the environment.
B.1.3. Exposure
Citations must report on at least one species included in one of the ﬁve groups of named species
speciﬁed in the EFSA QPS recommended list of the QPS 2016 update (see Table A1 in Appendix A to
(EFSA BIOHAZ Panel, 2017a)):
a) Gram-positive non-spore-forming bacteria;
b) Gram-positive spore-forming bacteria;
c) Gram-negative bacteria;
d) Viruses used for plant protection;
e) Yeasts.
In more detail:
a) Gram-positive non-spore forming bacteria:
Biﬁdobacterium adolescentis, Biﬁdobacterium animalis, Biﬁdobacterium biﬁdum, Biﬁdobacterium
breve, Biﬁdobacterium longum, Carnobacterium divergens, Corynebacterium glutamicum, Lactobacillus
acidophilus, Lactobacillus amylolyticus, Lactobacillus animalis, Lactobacillus amylovorus, Lactobacillus
alimentarius, Lactobacillus aviaries, Lactobacillus brevis, Lactobacillus buchneri, Lactobacillus casei,
Lactobacillus cellobiosus, Lactobacillus collinoides, Lactobacillus coryniformis, Lactobacillus crispatus,
Lactobacillus curvatus, Lactobacillus delbrueckii, Lactobacillus diolivorans Lactobacillus farciminis,
Lactobacillus fermentum, Lactobacillus gallinarum, Lactobacillus gasseri, Lactobacillus helveticus,
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Lactobacillus hilgardii, Lactobacillus johnsonii, Lactobacillus keﬁranofaciens, Lactobacillus keﬁri,
Lactobacillus mucosae, Lactobacillus panis, Lactobacillus paracasei, Lactobacillus paraplantarum,
Lactobacillus pentosus, Lactobacillus plantarum, Lactobacillus pontis, Lactobacillus reuteri, Lactobacillus
rhamnosus, Lactobacillus sakei, Lactobacillus salivarius, Lactobacillus sanfranciscensis, Lactococcus
lactis, Leuconostoc citreum, Leuconostoc lactis, Leuconostoc mesenteroides, Leuconostoc
pseudomesenteroides, Microbacterium imperiale, Oenococcus oeni, Pasteuria nishizawae, Pediococcus
acidilactici, Pediococcus dextrinicus, Pediococcus parvulus, Pediococcus pentosaceus, Propionibacterium
freudenreichii, Propionibacterium acidopropionici, Streptococcus thermophilus;
b) Gram-positive spore-forming bacteria:
Bacillus amyloliquefaciens, Bacillus atrophaeus, Bacillus clausii, Bacillus coagulans, Bacillus ﬂexus,
Bacillus fusiformis, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus mojavensis,
Bacillus pumilus, Bacillus smithii, Bacillus subtilis, Bacillus vallismortis, Geobacillus stearothermophilus;
c) Gram-negative bacteria:
Gluconobacter oxydans; Xanthomonas campestris
d) Viruses used for plant protection:
Plant viruses (Family): Alphaﬂexiviridae, Potyviridae
Insect viruses (Family): Baculoviridae
e) Yeasts:
Candida cylindracea, Debaryomyces hansenii, Hanseniaspora uvarum, Kluyveromyces lactis,
Kluyveromyces marxianus, Komagataella pastoris, Lindnera jadinii, Ogataea angusta, Saccharomyces
bayanus, Saccharomyces cerevisiae, Saccharomyces pastorianus, Schizosaccharomyces pombe,
Wickerhamomyces anomalus, Xanthophyllomyces dendrorhous.
For the yeast species, as previously, the name of the teleomorphic form is used in the list of QPS
species, when available. Important synonyms and older names were also included in the searches. For
instance, names of the anamorphic growth forms were included, when such a form is known:
• Debaryomyces hansenii: anamorph Candida famata;
• Hanseniaspora uvarum: anamorph Kloeckera apiculata;
• Kluyveromyces lactis: anamorph Candida spherica;
• Kluyveromyces marxianus: anamorph Candida kefyr;
• Komagataella pastoris: synonym Pichia pastoris;
• Lindnera jadinii: synonyms Pichia jadinii, Hansenula jadinii, Torulopsis utilis, anamorph Candida
utilis;
• Ogataea angusta: synonym Pichia angusta;
• Saccharomyces cerevisiae: synonym Saccharomyces boulardii;
• Saccharomyces pastorianus: synonym Saccharomyces carlsbergensis;
• Wickerhamomyces anomalus: synonyms Hansenula anomala, Pichia anomala, Saccharomyces
anomalus, anamorph Candida pelliculosa;
• Xanthophyllomyces dendrorhous: anamorph Phafﬁa rhodozyma.
B.1.4. Comparator
It is expected that the prevalent study designs will be case reports or case series and studies based
on surveys or isolate collections. The remaining study designs may include: studies using laboratory
isolates; randomised controlled trials, ﬁeld trials, or experimental designs in the laboratory;
experimental designs in live animals with a deliberate disease challenge; observational study designs;
animal or insect models; investigations to identify or to understand the causes of safety concerns (e.g.
identiﬁcation, characterisation of toxic factors, virulence mechanisms); studies to demonstrate
beneﬁcial effects but with reporting of unwanted side-effects.
Since it is expected that in the majority of the study designs relevant for the review question, the
comparator will not be available, the latter will not be included as a key element in the search strategy.
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B.1.5. Outcomes of interest
The outcomes of interest to this ELS are:
Question 1:
• potential harms;
• safety issues;
• virulence or infectivity;
• intoxication.
Question 2:
• (acquired/intrinsic) antimicrobial resistance (AMR) covering phenotypic and genotypic aspects.
The QPS concept does not address hazards linked to the formulation or processing of the products
based on biological agents added into the food or feed chain. Neither the safety of users handling the
product nor the genetic modiﬁcations are taken into account.
B.1.6. Identiﬁcation of the review questions
The following research questions will be addressed:
• Is there evidence of any safety concerns, including virulence features and toxin production, for
humans, animals, plants and/or the environment associated with microbial species currently
recommended for the QPS list since the previous QPS review (i.e. published from June 2016
until June 2019)?
• Is there evidence related to the presence or absence of antimicrobial resistance or antimicrobial
resistance genes for the same microbial species published during the same time period?
B.2. Eligibility criteria for study selection
The selection of studies relevant to questions 1 and 2 will be performed applying the eligibility
criteria described in Table B.1 below.
B.3. Literature searches
Searches will be conducted in a range of relevant information sources to identify any evidence of
safety concerns and AMR regarding the target microbial species.
Considering the results of the previous QPS exercise, to handle the high number of studies
identiﬁed in each group, 20 search strategies were prepared: three for yeasts, one for insect viruses,
one for plant viruses, 13 for Gram-positive bacteria and two for Gram-negative bacteria according to
named species speciﬁed by EFSA in the QPS recommended list of the QPS 2016 update (see Table A1
in Appendix A to (EFSA BIOHAZ Panel, 2017a)).
The 20 subgroups of target microbial species will be searched separately.
Each search strategy will comprise two elements: the search terms (Section B.3.1) and the
information sources (Section B.3.2) to be searched.
Table B.1: Eligibility criteria for questions 1 and 2
Criteria
Study design No speciﬁc type of study design will be used to include/exclude relevant studies, although it
is expected that the prevalent study designs will be case reports or case series and studies
based on surveys or isolate collections
Study
characteristics:
No exclusion will be based on study characteristics
Population Humans, animals, plants, environment
Exposure Studies must report on at least one TU as identiﬁed in Section B.1.3
Outcome of interest Outcomes as listed in Section B.1.5
Language English
Time From June 2016 until end June 2019
Publication type Primary research studies and secondary studies reporting previously unpublished primary
studies
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B.3.1. Search terms
The search strategies used to identify studies are given in Appendix C.
Each strategy will comprise two key elements:
• Target microbial species as described in Section B.1.3 (‘Exposure’);
• Safety issues as described in Section B.1.5 (‘Outcomes’).
In order to maximise the sensitivity of the search for the species for which the number of overall
publications in the relevant time period is expected to be low, the search strategy will not include
outcome-related terms.
The population of interest (humans, animals, plants or the environment) will not be included as a
key element in the search strategies, as it is often not explicitly described within a title or abstract. It
would also have been difﬁcult to describe adequately such a broad population using title/abstract
words and/or subject headings. Population information will be captured at the time of evaluating the
articles (see Section B.1 above).
Search terms for safety issues were identiﬁed in close collaboration with the information specialist;
example of such terms, are the following: ‘toxin*’, ‘disease*’, ‘infection*’, ‘clinical*’, ‘virulen*’,
‘antimicrobial resistan*’, ‘endocarditis’.
The 20 subgroups of target microbial species will be entered on separate search lines. The search
line for each group will be combined with the safety terms individually.
The searches will not be limited by language or study design.
The review period will be from June 2016 to June 2019.
B.3.2. Information sources searched
The same information sources used for the previous QPS exercise (EFSA BIOHAZ Panel, 2017a) will
be searched for studies reporting safety concerns regarding the target microbial species (see Table B.2
below).
Search results will be downloaded from the information sources and imported into EndNote® X8
bibliographic management software. For each of the 20 species groups, within-group removal of
duplicate entries will be done in EndNote® X8. Following uploading of the species groups into the
DistillerSR10 online software, removal of duplicates will again be undertaken, using the Duplicate
Detection feature.
B.4. Study selection and article evaluation
To identify potentially relevant studies to be included in the review the studies will be selected by a
three -step procedure using the DistillerSR online software.
The results of the different phases of the study selection process will be reported in a ﬂowchart as
recommended in the PRISMA statement on preferred reporting items for systematic reviews and meta-
analyses (Moher et al., 2009).
B.4.1. Screening for potential relevance at title level
Articles will initially be screened at title level in parallel by two Working Group (WG) expert
reviewers and, if needed, EFSA staff.
Table B.2: Information sources to be searched to identify relevant studies
Information source Interface
Web of Science Core Collection Web of Science, Thomson Reuters 2018
CAB Abstracts Web of Science, Thomson Reuters 2018
BIOSIS Citation Index Web of Science, Thomson Reuters 2018
MEDLINE Web of Science, Thomson Reuters 2018
Food Science Technology Abstracts (FSTA) Web of Science, Thomson Reuters 2018
10 DistillerSR, Evidence Partners, Ottawa, Canada. https://www.evidencepartners.com/products/distillersr-systematic-review-software/
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If the information in the title is not relevant for the research objectives, the article will not proceed
to the next step (Section B.4.2).
Articles that will be excluded during screening at this step will be stored in Distiller SR.
In case of doubts or divergences between the reviewers, the paper will proceed to step 2.
B.4.2. Screening for potential relevance at title and abstract level
The articles passing the ﬁrst step will undergo a screening at abstract level in parallel by two
experts.
If the information in title and abstract is not relevant for the research objectives, the article will not
proceed to the next step (Section B.4.3).
Articles that will be excluded during screening at this step will be stored in Distiller SR.
In case of doubts or divergences between the reviewers, the paper will proceed to step 3.
B.4.3. Article evaluation
The aim of this step will be to conﬁrm that the article is relevant for the QPS project and, in case it
is, to evaluate it. It will be carried out at full text level.
The articles passing the second step will undergo a validation procedure carried out by two experts.
One reviewer will initially be tasked with the evaluation of a paper. The evaluation will be then
forwarded to another reviewer for the validation of the appraisal received.
In case of disagreement with the initial appraisal, the second reviewer will write down their
comments. The reviewers will initially try to solve the disagreement. In case this will not be possible,
the conﬂicting information will be presented for collective expert evaluation of the ELS outcome (see
Section B.5).
If the information contained in the article is not relevant for the research objectives, the article will
not be evaluated. Articles that will not be considered relevant will be stored in Distiller SR.
B.4.3.1. Questions for study selection and article evaluation
STEP 1 (Screening for potential relevance):
Question 1: Is the full-text available, in English and dealing with safety concerns?
• Yes: Include and continue to Article evaluation form;
• Full text not available: Exclude;
• Full text not in English: Exclude;
• Full text in English but not dealing with safety concerns: Exclude.
STEP 2 (Article evaluation):
Question 2: Identiﬁcation of the microorganisms
• The article will be characterised in terms of the microorganisms involved
Single choice question: the Experts will identify the microorganism/s described in the article. In
case more than one microorganism is described in the paper, the form will be repeated for
each microorganism.
Question 3: Is there any “methodological” problem identiﬁed in the paper under consideration?
• No problems identiﬁed;
• Yes some problems were identiﬁed.
Question 4: Which “methodological” problems were identiﬁed in the paper under consideration?
(this question will appear in case in question 3 the option “Yes some problems were identiﬁed” will be
selected)
• Methodology used for identity conﬁrmation of the microorganism;
• Reliability of the source attribution;
• Misuse of the microorganism (e.g. parenteral exposure);
• Predisposing factors in the exposed subjects;
• Others.
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When one of the above options will be selected a dedicated free text box will appear to describe
the problem identiﬁed.
Question 5: Is there any safety concern identiﬁed? (this question will appear in case in question 3
the option “No problems identiﬁed” will be selected)
• No safety concerns identiﬁed;
• Yes some safety concerns were identiﬁed.
Question 6: Which safety concerns were identiﬁed? (this question will appear in case in question 5
the option “Yes some safety concerns were identiﬁed” will be selected)
• On human health;
• On animal health;
• On the environment;
• On the environment;
• On AMR;
• On other aspects.
When one of the above options will be selected a dedicated free text box will appear to describe
the safety concern identiﬁed.
Question 7: Overall, is there any information that could potentially lead to a change in the QPS
status of the microorganism? (this question will appear in case in question 5 the option “Yes some
safety concerns were identiﬁed” will be selected)
• No;
• Yes.
In case the option “Yes” will be selected a dedicated free text box will appear to describe the
information that could potentially lead to a change in the QPS status of the microorganism.
B.5. Collective expert evaluation of the ELS outcome and presentation
in the QPS opinion
The overall results of the searches and evaluations of individual articles will be presented in tabular
format for each group/sub-group and species. These results will be further evaluated collectively by
the working group and the outcome will be reﬂected in the QPS opinion.
B.6. Update of the process
The literature search, study selection and collective expert evaluation will be repeated every
6 months.
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Appendix C – Search strategies for the maintenance and update of list of
QPS-recommended biological agents (reply to ToR 2)
Gram-Positive Non-Spore-forming Bacteria
Biﬁdobacterium spp.
String for species
“Biﬁdobacterium adolescentis” OR “Biﬁdobacterium
animalis” OR “Biﬁdobacterium biﬁdum” OR
“Biﬁdobacterium breve” OR “Biﬁdobacterium longum”
OR “B adolescentis” OR “B animalis” OR “B biﬁdum” OR
“B breve” OR “B longum”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin*
3. Type of disease endocarditis OR abscess OR meningitis
4. Mortality/Morbidity clinical* OR death* OR morbidit* OR mortalit* OR
disease* OR illness*
5. Disease Risk opportunistic OR virulen*
Carnobacterium divergens
String for species
“Carnobacterium divergens” OR “C divergens”
OUTCOME String
6. Antimicrobial/Antibiotic/Antimycotic Not applied
7. Infection/Bacteremia/Fungemia/Sepsis Not applied
8. Type of disease Not applied
9. Mortality/Morbidity Not applied
10. Disease Risk Not applied
Corynebacterium glutamicum
String for species
“Corynebacterium glutamicum” OR “C glutamicum” OR
“Brevibacterium lactofermentum” OR “B
lactofermentum”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin* OR “pathogen*”
3. Type of disease Not applied
4. Mortality/Morbidity clinical* OR death* OR morbidit* OR mortalit* OR
disease* OR illness*
5. Disease Risk opportunistic OR virulen*
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Lactobacillus spp.
String for species
“Lactobacillus acidophilus” OR “Lactobacillus
amylolyticus” OR “Lactobacillus amylovorus” OR
“Lactobacillus alimentarius” OR “Lactobacillus animalis”
OR “Lactobacillus aviaries” OR “Lactobacillus brevis” OR
“Lactobacillus buchneri” OR “Lactobacillus casei” OR
“Lactobacillus zeae” OR “Lactobacillus cellobiosus” OR
“Lactobacillus coryniformis” OR “Lactobacillus crispatus”
OR “Lactobacillus curvatus” OR “Lactobacillus
delbrueckii” OR “Lactobacillus diolivorans” OR
“Lactobacillus farciminis” OR “Lactobacillus fermentum”
OR “Lactobacillus gallinarum” OR “Lactobacillus gasseri”
OR “Lactobacillus helveticus” OR “Lactobacillus hilgardii”
OR “Lactobacillus johnsonii” OR “Lactobacillus
keﬁranofaciens” OR “Lactobacillus keﬁri” OR
“Lactobacillus mucosae” OR “Lactobacillus panis” OR
“Lactobacillus collinoides” OR “Lactobacillus paracasei”
OR “Lactobacillus paraplantarum” OR “Lactobacillus
pentosus” OR “Lactobacillus plantarum” OR
“Lactobacillus pontis” OR “Lactobacillus reuteri” OR
“Lactobacillus rhamnosus” OR “Lactobacillus sakei” OR
“Lactobacillus salivarius” OR “Lactobacillus
sanfranciscensis” OR “L acidophilus” OR “L amylolyticus”
OR “L amylovorus” OR “L alimentarius” OR “L animalis”
OR “L aviaries” OR “L brevis” OR “L buchneri” OR “L
casei” OR “L zeae” OR “L cellobiosus” OR “L
coryniformis” OR “L crispatus” OR “L curvatus” OR “L
delbrueckii” OR “L diolivorans” OR “L farciminis” OR “L
fermentum” OR “L gallinarum” OR “L gasseri” OR “L
helveticus” OR “L hilgardii” OR “L johnsonii” OR “L
keﬁranofaciens” OR “L keﬁri” OR “L mucosae” OR “L
panis” OR “L collinoides” OR “L paracasei” OR “L
paraplantarum” OR “L pentosus” OR “L plantarum” OR
“L pontis” OR “L reuteri” OR “L rhamnosus” OR “L sakei”
OR “L salivarius” OR “L sanfranciscensis”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin*
3. Type of disease endocarditis OR abscess OR meningitis
4. Mortality/Morbidity Not applied
5. Disease Risk opportunistic OR virulen*
Lactococcus lactis
String for species
“Lactococcus lactis” OR “L lactis”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin*
3. Type of disease endocarditis OR abscess OR meningitis
4. Mortality/Morbidity clinical* OR death* OR morbidit* OR mortalit* OR
disease* OR illness*
5. Disease Risk opportunistic OR virulen*
BIOHAZ statement on QPS: suitability of taxonomic units notiﬁed until September 2018
www.efsa.europa.eu/efsajournal 29 EFSA Journal 2019;17(1):5555
Leuconostoc spp.
String for species
“Leuconostoc mesenteroides” OR “Leuconostoc lactis”
OR “Leuconostoc pseudomesenteroides” OR
“Leuconostoc citreum” OR “L mesenteroides” OR “L
lactis” OR “L pseudomesenteroides” OR “L citreum”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin*
3. Type of disease Not applied
4. Mortality/Morbidity clinical* OR death* OR morbidit* OR mortalit* OR
disease* OR illness*
5. Disease Risk opportunistic OR virulen*
Microbacterium imperiale
String for species
“Microbacterium imperiale” OR “M imperiale”
OUTCOME String
6. Antimicrobial/Antibiotic/Antimycotic Not applied
7. Infection/Bacteremia/Fungemia/Sepsis Not applied
8. Type of disease Not applied
9. Mortality/Morbidity Not applied
10. Disease Risk Not applied
Oenococcus spp.
String for species
“Oenococcus oeni” OR “O oeni”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk Not applied
Pasteuria nishizawae
String for species
“Pasteuria nishizawae” OR “P nishizawae”
OUTCOME String
11. Antimicrobial/Antibiotic/Antimycotic Not applied
12. Infection/Bacteremia/Fungemia/Sepsis Not applied
13. Type of disease Not applied
14. Mortality/Morbidity Not applied
15. Disease Risk Not applied
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Pediococcus spp.
String for species
“Pediococcus pentosaceus” OR “Pediococcus
dextrinicus” OR “Pediococcus acidilactici” OR
“Pediococcus parvulus” OR “P pentosaceus” OR “P
dextrinicus” OR “P acidilactici” OR “P parvulus”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk Not applied
Propionibacterium spp.
String for species Number papers retrieved and notes
“Propionibacterium acidipropionici” OR
“Propionibacterium freudenreichii” OR “P
acidipropionici” OR “P freudenreichii”
176
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk Not applied
Streptococcus thermophilus
String for species
“Streptococcus thermophilus” OR “S thermophilus”
“Streptococcus thermophilus” OR “S thermophilus”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin*
3. Type of disease Not applied
4. Mortality/Morbidity clinical* OR death* OR morbidit* OR mortalit* OR
disease* OR illness*
5. Disease Risk opportunistic OR virulen*
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Gram-Positive Spore-forming Bacteria
Bacillus spp.
String for species
“Bacillus amyloliquefaciens” OR “Bacillus coagulans” OR
“Bacillus clausii” OR “Bacillus atrophaeus” OR “Bacillus
ﬂexus” OR “Bacillus fusiformis” OR “Lysinibacillus
fusiformis” OR “Bacillus licheniformis” OR “Bacillus
lentus” OR “Bacillus mojavensis” OR “Bacillus
megaterium” OR “Bacillus vallismortis” OR “Bacillus
smithii” OR “Bacillus subtilis” OR “Bacillus pumilus” OR
“Geobacillus stearothermophilus” OR “B
amyloliquefaciens” OR “B coagulans” OR “B clausii” OR
“B atrophaeus” OR “B ﬂexus” OR “B fusiformis” OR “L
fusiformis” OR “B licheniformis” OR “B lentus” OR “B
mojavensis” OR “B megaterium” OR “B vallismortis” OR
“B smithii” OR “B subtilis” OR “B pumilus” OR “G
stearothermophilus”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antibiotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
bacteremia OR bacteraemia OR toxin*
3. Type of disease endocarditis OR abscess OR meningitis
4. Mortality/Morbidity Not applied
5. Disease Risk opportunistic OR virulen*
Gram-negative bacteria
Gluconobacter oxydans
String for species
“Gluconobacter oxydans” OR “G oxydans”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk Not applied
Xanthomonas campestris
String for species
“Xanthomonas campestris” OR “X campestris”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk Not applied
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Yeasts
TUs without keywords for OUTCOME
String for species
“Candida cylindracea” OR “Debaryomyces hansenii” OR
“Candida famata” OR “Hanseniaspora uvarum” OR
“Kloeckera apiculata” OR “Ogataea angusta” OR “Pichia
angusta” OR “Saccharomyces bayanus” OR
“Saccharomyces pastorianus” OR “Saccharomyces
carlsbergensis” OR “Wickerhamomyces anomalus” OR
“Hansenula anomala” OR “Pichia anomala” OR
“Saccharomyces anomalus” OR “Candida pelliculosa”
OR “Xanthophyllomyces dendrorhous” OR “Phafﬁa
rhodozyma” OR “C cylindracea” OR “D hansenii” OR “C
famata” OR “H uvarum” OR “K apiculata” OR “O
angusta” OR “P angusta” OR “S bayanus” OR “S
pastorianus” OR “S carlsbergensis” OR “W anomalus”
OR “H anomala” OR “P anomala” OR “S anomalus” OR
“C pelliculosa” OR “X dendrorhous” OR “P rhodozyma”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk Not applied
TUs with keywords for OUTCOME except for type of disease and morbility/mortality
String for species
“Kluyveromyces lactis” OR “Candida spherica” OR
“Kluyveromyces marxianus” OR “Candida kefyr” OR
“Komagataella pastoris” OR “Pichia pastoris” OR
“Lindnera jadinii” OR “Pichia jadinii” OR “Hansenula
jadinii” OR “Torulopsis utilis” OR “Candida utilis” OR
“Schizosaccharomyces pombe” OR “K lactis” OR “C
spherica” OR “K marxianus” OR “C kefyr” OR “K
pastoris” OR “P pastoris” OR “L jadinii” OR “P jadinii”
OR “H jadinii” OR “T utilis” OR “C utilis” OR “S pombe”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antimycotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
fungemia OR fungaemia OR mycos*
3. Type of disease Not applied
4. Mortality/Morbidity Not applied
5. Disease Risk opportunistic OR virulen*
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TUs with keywords for OUTCOME except for type of disease
String for species
“saccharomyces cerevisiae” OR “saccharomyces
boulardii” OR “s cerevisiae” OR “s boulardii”
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic “antimicrobial resistan*” OR “antimycotic resistan*” OR
“antimicrobial susceptibil*”
2. Infection/Bacteremia/Fungemia/Sepsis infection* OR abscess* OR sepsis* or septic* OR
fungemia OR fungaemia OR mycos*
3. Type of disease Not applied
4. Mortality/Morbidity clinical* OR death* OR morbidit* OR mortalit* OR
disease* OR illness*
5. Disease Risk opportunistic OR virulen*
Viruses used for plant protection
Alphaﬂexiviridae
String for species
Alphaﬂexiviridae OR Potyviridae
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis necros*
3. Type of disease Not applied
4. Mortality/Morbidity mortalit* OR “safety concern*” OR “health hazard”
5. Disease Risk virulen*
Baculoviridae
String for species
“Nuclear polyhedrosis virus” OR granulovirus OR
baculoviridae
OUTCOME String
1. Antimicrobial/Antibiotic/Antimycotic Not applied
2. Infection/Bacteremia/Fungemia/Sepsis Not applied
3. Type of disease “nuclear polyhedrosis” OR granulosis
4. Mortality/Morbidity mortalit* OR “safety concern*” OR “health hazard”
5. Disease Risk Not applied
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Appendix D – References selected from the ELS exercise as relevant for
the QPS for searches from January to June 2018 (reply to ToR 2)
Gram-Positive Non-Sporulating Bacteria
Biﬁdobacterium spp.
Martinez N, Luque R, Milani C, Ventura M, Banuelos O and Margolles A, 2018. A gene homologous to rRNA
methylase genes confers erythromycin and clindamycin resistance in Biﬁdobacterium breve. Applied and
Environmental Microbiology, 84.
Kim MJ, Ku S, Kim SY, Lee HH, Jin H, Kang S, Li R, Johnston TV, Park MS and Ji GE, 2018. Safety Evaluations of
Biﬁdobacterium biﬁdum BGN4 and Biﬁdobacterium longum BORI. International Journal of Molecular Sciences,
19.
Kumar K, Saadi M, Ramsey FV, Schey R and Parkman HP, 2018. Effect of Biﬁdobacterium infantis 35624 (Align)
on the lactulose breath test for small intestinal bacterial overgrowth. Digestive Diseases and Sciences, 63,
989–995.
Simpson MR, Avershina E, Storro O, Johnsen R, Rudi K and Oien T, 2018. Breastfeeding-associated microbiota in
human milk following supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus La-5, and
Biﬁdobacterium animalis ssp. lactis Bb-12. Journal of Dairy Science, 101, 889–899.
de Andres J, Jimenez E, Chico-Calero I, Fresno M, Fernandez LM and Rodriguez J, 2018. Physiological translocation
of lactic acid bacteria during pregnancy contributes to the composition of the milk microbiota in mice.
Nutrients, 10.
Downes KL, Ravel JG, Pawel E and Michal A, 2018. Speciﬁc microbes present in the early third trimester in the
cervicovaginal space are associated with spontaneous labor at term. American Journal of Obstetrics and
Gynecology, 218, S239–S240.
Carnobacterium divergens
None.
Corynebacterium glutamicum
None.
Lactobacilli spp.
de Seynes C, Dutronc H, Cremer P and Dupon M, 2018. Lactobacillus casei prosthetic joint infection. Medecine et
Maladies Infectieuses.
Biesiada G, Krycinska R, Czepiel J, Stazyk K, Kedzierska J and Garlicki A, 2018. Meningoencephalitis caused by
Lactobacillus plantarum - case report. The International Journal of Neuroscience, 1–9.
Boumis E, Capone A, Galati V, Venditti C and Petrosillo N, 2018. Probiotics and infective endocarditis in patients
with hereditary hemorrhagic telangiectasia: a clinical case and a review of the literature. BMC Infectious
Diseases, 18.
Harding-Theobald E and Maraj B, 2018. Spontaneous Bacterial Peritonitis due to Lactobacillus paracasei in
Cirrhosis. Case Reports in Gastrointestinal Medicine.
Garcia Carretero R, Regodon Dominguez M, Ruiz Bastian M and Lopez Lomba M, 2018. Lactobacillus salivarius
infection as a postoperative complication after bariatric surgery. Enfermedades Infecciosas Y Microbiologia
Clinica, 36, 60–61.
Kane AF, Bhatia AD, Denning PW, Shane AL and Patel RM, 2018. Routine Supplementation of Lactobacillus
rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants. Journal of Pediatrics,
195, 73-+.
Koyama S, Fujita H, Shimosato T, Kamijo A, Ishiyama Y, Yamamoto E, Ishii Y, Hattori Y, Hagihara M, Yamazaki E,
Tomita N, Nakajima H and Yokohama Cooperative Study Group for, Hematology, 2018. Septicemia from
Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell
Transplantation. Probiotics and Antimicrobial Proteins.
Lactococcus lactis
Georgountzos G, Michopoulos C, Grivokostopoulos C, Kolosaka M, Vlassopoulou N and Lekkou A, 2018. Infective
endocarditis in a young adult due to Lactococcus lactis: a case report and review of the literature. Case
Reports in Medicine.
Wunnemann H, Eskens U, Prenger-Berninghoff E, Ewers C and Lierz M, 2018. Lactococcus lactis, causative agent
of an endocarditis valvularis and parietalis thromboticans in the allis shad, Alosa alosa (L.). Journal of Fish
Diseases.
Mussano F, Ferrocino I, Gavrilova N, Genova T, Dell’Acqua A, Cocolin L and Carossa S, 2018. Apical periodontitis:
preliminary assessment of microbiota by 16S rRNA high throughput amplicon target sequencing. BMC Oral
Health, 18.
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Tato Rodriguez R, Guzman Figueroa DM, Trigo Daporta M and Garcia Campello M, 2018. Fever in an 80-year-old
male carrying biologic aortic prosthesis endocarditis due to Lactococcus lactis subsp lactis. Journal of Clinical
Microbiology, 56.
Leuconostoc spp.
Mussano F, Ferrocino I, Gavrilova N, Genova T, Dell’Acqua A, Cocolin L and Carossa S, 2018. Apical periodontitis:
preliminary assessment of microbiota by 16S rRNA high throughput amplicon target sequencing. BMC Oral
Health, 18.
Vahabzadeh S and Ozpinar H, 2018. Investigation of some biochemical properties, antimicrobial activity and
antibiotic resistances of keﬁr supernatants and Lactococcus lactis ssp. lactis Strains isolated from raw cow milk
and cheese samples. Kafkas Universitesi Veteriner Fakultesi Dergisi, 24, 443–450.
Lin X, Jiang Q, Liu J, Zhao F and Chen W, 2018. Leuconostoc pseudomesenteroides-associated hemophagocytic
syndrome: a case report. Experimental and Therapeutic Medicine, 15, 1199–1202.
Microbacterium imperiale
None.
Oenococcus oeni
None.
Pasteuria nishizawae
None.
Pediococcus spp.
None.
Propionibacterium spp.
None.
Streptococcus thermophilus
None.
Gram-Positive Spore-forming Bacteria
Bacillus spp.
Kim MK, Yoon HY, Lee MH and Kim JH, 2018. Canine pyometra associated with Bacillus species: a
case report. Veterinarni Medicina, 63, 143–149.
Tran TT, Varghese M and Baer S, 2018. Polymicrobial endocarditis caused by abiotrophia defectiva,
Bacillus cereus, Bacillus subtilis and Bacillus megaterium in the setting of injection drug use. Journal of
Investigative Medicine, 66, 473–473.
Geobacillus stearothermophilus
None.
Gram-negative bacteria
Gluconobacter oxydans
None.
Xanthomonas campestres
Sundin GW and Wang N, 2018. Antibiotic Resistance in Plant-Pathogenic Bacteria. Annual Review of
Phytopathology.
Yeasts11
Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, Khodavaisy S, Boekhout T and Badali H, 2018.
Identiﬁcation of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infectious
Diseases, 18.
11 See also Table D.1.
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Al-Tekreeti ARA, Al-Halbosiy MMF, Dheeb BI, Hashim AJ, Al-Zuhairi AFH and Mohammad FI, 2018. Molecular
identiﬁcation of clinical Candida isolates by simple and randomly ampliﬁed polymorphic DNA-PCR. Arabian
Journal for Science and Engineering, 43, 163–170.
Charsizadeh A, Mirhendi H, Nikmanesh B, Eshaghi H, Rahmani M, Farhang A, Bakhshi H and Makimura K, 2018.
Candidemia in Children Caused by Uncommon Species of Candida. Archives of Pediatric Infectious Diseases, 6.
Dangarembizi R, Erlwanger KH, Rummel C, Roth, J, Madziva MT and Harden LM, 2018. Brewer’s yeast is a potent
inducer of fever, sickness behavior and inﬂammation within the brain. Brain Behavior and Immunity, 68,
211–223.
Charsizadeh A, Nikmanesh B, Ahmadi B, Jalalizand N, Jafari Z, Rahmani M, Kordbacheh P and Mirhendi H, 2018.
Frequency of Candida Species Isolated from Patients in Children’s Medical Center, Tehran, Iran. Archives of
Pediatric Infectious Diseases, 6.
Charsizadeh A, Mirhendi H, Nikmanesh B, Eshaghi H and Makimura K, 2018. Microbial epidemiology of
candidaemia in neonatal and paediatric intensive care units at the Children’s Medical Center, Tehran. Mycoses,
61, 22–29.
Denis B, Chopin D, Piron P, Resche-Rigon M, Bretagne S, Gits-Muselli M, Peraldi M-N, Abboud I and Molina J-M,
2018. Candiduria in kidney transplant recipients: Is antifungal therapy useful? Mycoses, 61, 298–304.
Gaisne R, Jeddi F, Morio F, Le Clerc Q-C, Hourmant M, Blancho G, Giral M, Cantarovich D, Dantal J and Ville S,
2018. Candida utilis fungaemia following endoscopic intervention on ureteral stent in a kidney transplant
recipient: Case report and a review of the literature. Mycoses.
Jahanshiri Z, Manifar S, Moosa H, Asghari-Paskiabi F, Mahmoodzadeh H, Shams-Ghahfarokhi M and Razzaghi-
Abyaneh M, 2018. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identiﬁcation,
antifungal susceptibility and pathogenic characterization. Journal de Mycologie Medicale, 28, 361–366.
Kumari S, Dey S, Sena A, Kumar D and Akhter K, 2018. Characterisation and antifungal susceptibility testing of
Candida species isolated from clinical samples of patients attending Katihar Medical College, Katihar. BIHAR
Journal of Evolution of Medical and Dental Sciences-Jemds, 7, 662–666.
Li M-C, Chang TC, Chen H-M, Wu C-J, Su S-L, Lee SSJ, Chen P-L, Lee N-Y, Lee C-C, Li C-W, Syue L-S and Ko W-C,
2018. Oligonucleotide Array and VITEK Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass
Spectrometry in Species Identiﬁcation of Blood Yeast Isolates. Frontiers in Microbiology, 9.
Ortiz B, Perez-Aleman E, Galo C and Fontecha G, 2018. Molecular identiﬁcation of Candida species from urinary
infections in Honduras. Revista Iberoamericana De Micologia, 35, 73–77.
Mount H, Revie NM, Todd RT, Anstett K, Collins C, Costanzo M, Boone C, Robbins N, Selmecki A and Cowen LE,
2018. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal
drugs. Plos Genetics, 14.
Musatti A, Mapelli C, Rollini M, Foschino R, Picozzi C, 2018. Can Zymomonas mobilis Substitute Saccharomyces
cerevisiae in Cereal Dough Leavening? Foods, 7.
Mohamed, Nurul Azmawati,Pathmanathan, Siva Gowri,Hussin, Hazilawati,Zaini, Adilahtul Bushro (2018).
Distribution and Antifungal Susceptibility Pattern of Candida species at a Tertiary Hospital in Malaysia. Journal
of Infection in Developing Countries, 12(2), 102-108.
Nejat, Ziba Abbasi,Farahyar, Shirin,Falahati, Mehraban,Khozani, Mahtab Ashraﬁ,Hosseini, Aga Fateme,Faiazy,
Azamsadat,Ekhtiari, Masoome,Hashemi-Hafshenjani, Saeideh (2018). Molecular Identiﬁcation and Antifungal
Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis. Iranian
Biomedical Journal, 22(1), 33-41.
Mixao, Veronica,Gabaldon, Toni (2018). Hybridization and emergence of virulence in opportunistic human yeast
pathogens. Yeast, 35(1), 5-20.
Robledo-Leal, E.,Rivera-Morales, L. G.,Sangorrin, M. P.,Gonzalez, G. M.,Ramos-Alfano, G.,Adame-Rodriguez, J. M.,
Alcocer-Gonzalez, J. M.,Arechiga-Carvajal, E. T.,Rodriguez-Padilla, C. (2018). Identiﬁcation and susceptibility of
clinical isolates of Candida spp. to killer toxins. Brazilian journal of biology = Revista brasleira de biologia, 78
(4), 742-749.
Rajkowska K and Kunicka-Styczynska A, 2018. Typing and virulence factors of food-borne Candida spp. isolates.
International Journal of Food Microbiology, 279, 57–63.
Rosenberg A, Ene IV, Bibi M, Zakin S, Segal ES, Ziv N, Dahan AM, Colombo AL, Bennett RJ and Berman J, 2018.
Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent
candidemia. Nature Communications, 9.
Scapaticci M, Bartolini A, Del Chierico F, Accardi C, Di Girolamo F, Masotti A, Muraca M and Putignani L, 2018.
Phenotypic typing and epidemiological survey of antifungal resistance of Candida species detected in clinical
samples of Italian patients in a 17 months’ period. Germs, 8, 58–66.
Sav H, Baris A, Turan D, Altinbas R and Sen S, 2018. The frequency, antifungal susceptibility and enzymatic
proﬁles of Candida species in cases of onychomycosis infection. Microbial Pathogenesis, 116, 257–262.
Phadke SS, Maclean CJ, Zhao SY, Mueller EA, Michelotti LA, Norman KL, Kumar A and James TY, 2018. Genome-
Wide Screen for Saccharomyces cerevisiae Genes Contributing to Opportunistic Pathogenicity in an
Invertebrate Model Host. G3-Genes Genomes Genetics, 8, 63–78.
Scott LH, Mathews JC, Flematti GR, Filipovska A and Rackham O, 2018. An artiﬁcial yeast genetic circuit enables
deep mutational scanning of an antimicrobial resistance protein. ACS Synthetic Biology.
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Suwunnakorn S, Wakabayashi H, Kordalewska M, Perlin DS and Rustchenko E, 2018. FKS2 and FKS3 Genes of
Opportunistic Human Pathogen Candida albicans Inﬂuence Echinocandin Susceptibility. Antimicrobial Agents
and Chemotherapy, 62.
Siavoshi F, Sahraee M, Ebrahimi H, Sarrafnejad A and Saniee P, 2018. Natural fruits, ﬂowers, honey, and
honeybees harbor Helicobacter pylori-positive yeasts. Helicobacter, 23.
Steenkamp ET, Wingﬁeld MJ, McTaggart AR and Wingﬁeld BD, 2018. Fungal species and their boundaries matter -
Deﬁnitions, mechanisms and practical implications. Fungal Biology Reviews, 32, 104–116.
Sivamaruthi BS, 2018. A comprehensive review on clinical outcome of probiotic and synbiotic therapy for
inﬂammatory bowel diseases. Asian Paciﬁc Journal of Tropical Biomedicine, 8, 179–186.
Sekyere JO and Asante J, 2018. Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances
in the era of genomics. Future Microbiology, 13, 241–262.
Vieira JN, Feijo AM, Bueno ME, Goncalves CL, Lund RG, Mendes JF, Villarreal JPV, Villela MM and Nascente PS,
2018. Evaluation of the frequency of Candida spp. in hospitalized and non-hospitalized subjects. Brazilian
Journal of Biology = Revista brasleira de biologia, 78, 644–652.
Taverna CG, Cordoba S, Vivot M, Szusz W, Vivot W, Bosco-Borgeat ME and Davel G, 2018. Reidentiﬁcation and
antifungal susceptibility proﬁle of Candida guilliermondii and Candida famata clinical isolates from a culture
collection in Argentina. Medical Mycology.
Wayakanon K, Rueangyotchanthana K, Wayakanon P and Suwannachart C, 2018. The inhibition of Caco-2
proliferation by astaxanthin from Xanthophyllomyces dendrorhous. Journal of Medical Microbiology, 67, 507–
513.
Wasilewska E and Wroblewska B, 2018. Effectiveness and safety of probiotic preparations in clinical treatment of
inﬂammatory bowel disease. Postepy Higieny I Medycyny Doswiadczalnej, 72, 159–174.
Yenisehirli G, Ozveren G, Yenisehirli A and Bulut Y, 2018. In vitro susceptibilities of non-albicans Candida Species to
Echinocandins, Azoles, and Amphotericin B in Tokat, Turkey. Jundishapur Journal of Microbiology, 11, e59404.
Yang YC and Mao J, 2018. Value of platelet count in the early diagnosis of nosocomial invasive fungal infections in
premature infants. Platelets, 29, 65–70.
Viruses used for plant protection
Alphaﬂexiviridae
None.
Baculoviridae
None.
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Table D.1: Articles that arrived to the article evaluation phase for the QPS status yeasts group
Thirty-ﬁve articles reached the article evaluation phase (ﬁnal step of the ELS) for the QPS status yeasts group.(a),(b)
Not
relevant
for the
QPS
exercise
Articles
not in
English,
no full
text or
not
describing
safety
concerns
14 ref. Denis et al. (2018), Gaisne et al. (2018), Li et al. (2018), Mount et al. (2018), Musatti et al. (2018), Mixao and Gabaldon (2018),
Robledo-Leal et al. (2018), Rosenberg et al. (2018), Scott et al. (2018), Steenkamp et al. (2018), Steenkamp et al. (2018), Phadke
et al. (2018), Sivamaruthi (2018), Wayakanon et al. (2018)
Relevant
to the
QPS
exercise
Articles
dealing
with
safety
concerns
21 ref. Aslani et al. (2018),
Al-Tekreeti et al.
(2018), Charsizadeh
c) et al. (2018),
Dangarembizi et al.
(2018), Charsizadeh
(b) et al. (2018),
Charsizadeh (a) et al.
(2018), Jahanshiri
et al. (2018), Kumari
et al. (2018), Ortiz
et al. (2018),
Mohamed et al.
(2018), Nejat et al.
(2018), Rajkowska
et al. (2018),
Scapaticci et al.
(2018), Sav et al.
(2018), Siavoshi et al.
(2018), Sekyere et al.
(2018), Vieira et al.
(2018), Taverna et al.
(2018), Wasilewska
et al. (2018),
Yenisehirli et al.
(2018), Yang and Mao
(2018)
Any
methodological
problem
identiﬁed?
Yes 6 ref. Article(s)
not
considered
because
of:
Methodology
used for
identity
conﬁrmation
of the
microorganism
6 ref. Kumari et al. (2018),
Mohamed et al. (2018),
Rajkowska et al. (2018),
Vieira et al. (2018),
Yenisehirli et al. (2018),
Yang and Mao (2018)
Reliability of
the source
attribution
3 ref. Rajkowska et al. (2018),
Vieira et al. (2018),
Yenisehirli et al. (2018)
Misuse of the
microorganism
0 ref.
Predisposing
factors in the
exposed
subjects
1 ref. Yang and Mao (2018)
Other reasons 0 ref.
No 15 ref. Articles
describing
any safety
concern
on:
Human health 13 ref. Aslani et al. (2018),
Al-Tekreeti et al. (2018),
Charsizadeh c) et al.
(2018), Charsizadeh
(b) et al. (2018),
Charsizadeh (a)
et al. (2018), Jahanshiri
et al. (2018), Ortiz et al.
(2018), Nejat et al.
(2018), Scapaticci
et al. (2018), Sav
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et al. (2018), Siavoshi
et al. (2018), Taverna
et al. (2018),
Wasilewska et al. (2018)
Animal health 1 ref. Dangarembizi
et al. (2018)
Environment 0 ref.
AMR 4 ref. Scapaticci et al. (2018),
Sav et al. (2018),
Sekyere et al. (2018),
Taverna et al. (2018)
Other aspects 0 ref. 0
(a): Please refer to Appendix D for the complete list of references.
(b): Number of references (ref.) indicated for each step.
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Appendix E – The 2016 updated list of QPS Status recommended biological
agents in support of EFSA risk assessments
The list of QPS status recommended biological agents (EFSA BIOHAZ Panel, 2016) is being
maintained in accordance with the self-task mandate of the BIOHAZ Panel (2017–2019). Possible
additions to this list are included around every 6 months, with the ﬁrst Panel Statement adopted in
June 2017 and the last Panel Statement planned for adoption in December 2019. These additions are
published as updates to the Scientiﬁc Opinion (EFSA BIOHAZ Panel, 2016); the latest update is
available at https://doi.org/10.2903/j.efsa.2017.4664 and, as of January 2018, also as supporting
information linked to every Panel Statement available on the Knowledge Junction at https://doi.org/10.
5281/zenodo.1146566.
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Appendix F – Microbial species as notiﬁed to EFSA, received between April and September 2018 (reply to ToR 1)
EFSA risk
assessment
area
Microorganism species/
strain
Intended use
EFSA Question
number(a) and
EFSA webpage
link(b)
Additional
information
provided by the
EFSA Scientiﬁc Unit
Previous
QPS
status?(c)
To be
evaluated?
yes or no(d)
Bacteria
Feed additives Bacillus amyloliquefaciens DSM
25840
Zootechnical additive EFSA-Q-2018-00678 Gut ﬂora stabilisers Yes No
Feed additives Bacillus licheniformis DSM 5749
and Bacillus subtilis DSM 5750
Zootechnical additive EFSA-Q-2018-00668 Gut ﬂora stabilisers Yes No
Feed additives Bacillus licheniformis ENV01/
DSM 32457
Technological additive EFSA-Q-2018-00690 Silage additives Yes No
Feed additives Bacillus subtilis C-3102, DSM
15544
Zootechnical additive EFSA-Q-2018-00677 Gut ﬂora stabilisers Yes No
Feed additives Bacillus subtilis DSM 25841 Zootechnical additive EFSA-Q-2018-00679 Gut ﬂora stabilisers Yes No
Feed additives Bacillus subtilis DSM 28343 Zootechnical additive
Production of L-arginine
EFSA-Q-2018-00584 Gut ﬂora stabilisers Yes No
Feed additives Bacillus subtilis LMG S-27588 Zootechnical additive
Production of endo-1,4-beta-xylanase
EFSA-Q-2018-00669 Digestibility enhancers Yes No
Feed additives Corynebacterium glutamicum* Nutritional additive
Production of lysine
EFSA-Q-2018-00427 Amino acids Yes No
Feed additives Corynebacterium glutamicum* Nutritional additive
Production of L-lysine monohydrochloride
and concentrated liquid L-lysine (base)
EFSA-Q-2018-00507 Amino acids Yes No
Food enzymes,
food additives
and ﬂavourings
Corynebacterium glutamicum*
(strain FIS002)
Production of food enzyme D-psicose
3-epimerase
EFSA-Q-2018-00115 Yes No
Novel Food Corynebacterium glutamicum*
(strain FIS002)
Novel Food
Production of allulose which involves the
epimerisation of fructose at the C-3
position, in a reaction catalysed by D-
psicose 3-epimerase, which is contained
within a non-viable, immobilised
Corynebacterium glutamicum FIS002
EFSA-Q-2018-00472 Summary of
application: https://
ec.europa.eu/food/site
s/food/files/safety/doc
s/novel-food_sum_
ongoing-app_allulose.
pdf
Yes No
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EFSA risk
assessment
area
Microorganism species/
strain
Intended use
EFSA Question
number(a) and
EFSA webpage
link(b)
Additional
information
provided by the
EFSA Scientiﬁc Unit
Previous
QPS
status?(c)
To be
evaluated?
yes or no(d)
Feed additives Corynebacterium glutamicum*
KCCM 10227
Nutritional additive
Production by fermentation of L-lysine of
monohydrochloride and concentrated
liquid lysine
EFSA-Q-2018-00442 Amino acids Yes No
Feed additives Corynebacterium glutamicum*
KCCM 80117
Nutritional additive
Production by fermentation of
L-threonine
EFSA-Q-2018-00506 Amino acids Yes No
Feed additives Corynebacterium glutamicum*
KCCM 80172
Nutritional additive
Production of histidine
EFSA-Q-2018-00438 Amino acids Yes No
Feed additives Corynebacterium glutamicum*
KCCM 80176
Nutritional additive
Production of tryptophane
EFSA-Q-2018-00451 Amino acids Yes No
Feed additives Corynebacterium glutamicum*
KCCM 80178
Nutritional additive
Production of L-threonine
EFSA-Q-2018-00627 Amino acids Yes No
Feed additives Corynebacterium glutamicum*
KCCM 80179
Nutritional additive/Sensory additive
Production by fermentation of L-histidine
monohydrochloride monohydrate
EFSA-Q-2018-00547 Amino acids/Flavouring
compounds
Yes No
Feed additives Corynebacterium glutamicum*
KCCM 80182
Nutritional additive/Sensory additive
Production of L-arginine
EFSA-Q-2018-00612 Amino acids/Flavouring
compounds
Yes No
Feed additives Corynebacterium glutamicum*
NITE BP-02524
Nutritional additive/Sensory additive
Production of L-glutamine
EFSA-Q-2018-00693 Amino acids/Flavouring
compounds
Yes No
Feed additives Enterococcus faecium DSM
7134
Zootechnical additive EFSA-Q-2018-00419 Gut ﬂora stabilisers No No
Feed additives Enterococcus faecium DSM
7134
Zootechnical additive EFSA-Q-2018-00647 Gut ﬂora stabilisers No No
Feed additives Escherichia coli CGMCC 11473 Nutritional additive
Production of L-threonine
EFSA-Q-2018-00695 Amino acids No No
Novel foods Escherichia coli commercial
strain BL21 (DE3) Expression
strain
Novel Food
Production of a recombinant protein
EFSA-Q-2018-00316 Summary of this
application: https://
ec.europa.eu/food/site
s/food/files/safety/doc
s/novel-food_sum_
ongoing-app_apoae
quorin.pdf
No No
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EFSA risk
assessment
area
Microorganism species/
strain
Intended use
EFSA Question
number(a) and
EFSA webpage
link(b)
Additional
information
provided by the
EFSA Scientiﬁc Unit
Previous
QPS
status?(c)
To be
evaluated?
yes or no(d)
Feed additives Escherichia coli K12 KCCM
80159
Nutritional additive
Production by fermentation of
L-valine
EFSA-Q-2018-00712 Amino acids No No
Feed additives Escherichia coli KCCM 10534 Nutritional additive
Production by fermentation of
L-tryptophan
EFSA-Q-2018-00545 Amino acids No No
Feed additives Escherichia coli KCCM 80180
and Escherichia coli KCCM
80181
Sensory additive
Production by fermentation of
L-cysteine monohydrochloride
monohydrate
EFSA-Q-2018-00552 Flavouring compounds No No
Feed additives Escherichia coli NITE BP-02351 Nutritional additive/Sensory additive
Production of L-leucine
EFSA-Q-2018-00548 Amino acids/Flavouring
compounds
No No
Feed additives Escherichia coli NITE SD 00268 Nutritional additive
Production of L-histidine
monohydrochloride monohydrate
EFSA-Q-2018-00546 Amino acids No No
Novel foods Komagataeibacter
sucrofermentans
Novel Food EFSA-Q-2018-00294 Summary of this
application: https://
ec.europa.eu/food/site
s/food/ﬁles/safety/doc
s/novel-food_sum_
ongoing-app_bacterial-
cellulose.pdf
No Yes
Feed additives Lactobacillus farciminis CNCM
I-3699
Zootechnical additive EFSA-Q-2018-00422 Other zootechnical
additives
Yes No
Feed additives Lactobacillus hilgardii CNCM I-
4785 and Lactobacillus buchneri
CNCM I-4323
Technological additive EFSA-Q-2018-00287 Silage additive Yes No
Feed additives Lactobacillus rhamnosus CNCM
I-3698
Zootechnical additive EFSA-Q-2018-00422 Other zootechnical
additives
Yes No
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EFSA risk
assessment
area
Microorganism species/
strain
Intended use
EFSA Question
number(a) and
EFSA webpage
link(b)
Additional
information
provided by the
EFSA Scientiﬁc Unit
Previous
QPS
status?(c)
To be
evaluated?
yes or no(d)
Novel foods Mycobacterium setense strain
Manresensis
Novel Food EFSA-Q-2018-00278 Summary of this
application: https://
ec.europa.eu/food/site
s/food/ﬁles/safety/doc
s/novel-food_sum_
ongoing-app_heat-
killed-mycobacterium.
pdf
No Yes
Feed additives Pediococcus acidilactici CNCM
MA 18/5M
Zootechnical additive EFSA-Q-2018-00632 Other zootechnical
additives
Yes No
Feed additives Pediococcus acidilactici CNCM
MA 18/5M
Zootechnical additive EFSA-Q-2018-00641 Gut ﬂora stabilisers Yes No
Feed additives Pseudomonas ﬂuorescens
BD50104
Zootechnical additive
Production of 6-phytase
EFSA-Q-2018-00421 Digestibility enhancers No Yes
Food enzymes,
food additives
and ﬂavourings
Streptomyces mobaraensis
(strain DSM40587)
Production of food enzyme
transglutaminase
EFSA-Q-2017-00615 No No
Filamentous fungi
Feed additives Aspergillus niger CBS DSM
25770
Zootechnical additive
Production of 6-phytase
EFSA-Q-2018-00623 Digestibility enhancers
GMM
No No
Feed additives Aspergillus niger (CBS 109.713
and DSM 18404)
Zootechnical additive
Production of endo-1,4-beta-xylanase
and endo-1,4-beta-glucanase
EFSA-Q-2018-00417 Digestibility enhancers
GMM
No No
Food enzymes,
food additives
and ﬂavourings
Aspergillus niger (NZYM-BF) Production of food enzyme
glucoamylase
EFSA-Q-2018-00265 No No
Feed additives Aspergillus oryzae DSM 10287 Zootechnical additive
Production of endo-1,4-beta-xylanase
EFSA-Q-2018-00622 Digestibility enhancers
GMM
No No
Feed additives Trichoderma citrivirinode IMI
SD142
Zootechnical additive
Production of endo-1,4-beta-xylanase
EFSA-Q-2018-00420 Digestibility enhancers No No
Yeasts
Feed additives Komagataella pastoris CGMCC
12056
Zootechnical additive
Production of 6-phytase
EFSA-Q-2018-00478 Digestibility enhancers
GMM
Yes No
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EFSA risk
assessment
area
Microorganism species/
strain
Intended use
EFSA Question
number(a) and
EFSA webpage
link(b)
Additional
information
provided by the
EFSA Scientiﬁc Unit
Previous
QPS
status?(c)
To be
evaluated?
yes or no(d)
Feed additives Saccharomyces cerevisiae
CNCM I-1077
Zootechnical additive EFSA-Q-2018-00630 Digestibility enhancers
and Gut ﬂora
stabilisers
Yes No
Feed additives Saccharomyces cerevisiae
CNCM I-1079
Zootechnical additive EFSA-Q-2018-00473 Gut ﬂora stabilisers Yes No
Feed additives Saccharomyces cerevisiae
CNCM I-1079
Zootechnical additive EFSA-Q-2018-00631 Other zootechnical
additives
Yes No
Feed additives Saccharomyces cerevisiae MUCL
39885
Zootechnical additive EFSA-Q-2018-00474 Gut ﬂora stabilisers Yes No
Feed additives Schizosaccharomyces pombe
(ATCC SD 5233)
Zootechnical additive
Production of 6-phytase
EFSA-Q-2018-00516 Digestibility enhancers
GMM
Yes No
*: Qualiﬁcation that QPS only applies when the species is used for amino acid production is extended to other production purposes uses in this Panel Statement.
(a): To ﬁnd more details on speciﬁc applications please access the EFSA website - Register of Questions: http://registerofquestions.efsa.europa.eu/roqFrontend/ListOfQuestionsNoLogin?0&panel=
ALL
(b): Where no link is given this means that the risk assessment has not yet been published.
(c): Included in the QPS list as adopted in December 2016 (EFSA BIOHAZ Panel, 2017a,b) and respective updates which include new additions (latest: EFSA BIOHAZ Panel, 2018a,b).
(d): In the current Panel Statement.
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